National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)
made under sections 84AF, 84AK, 85, 85A, 88 and 101 of the
National Health Act 1953
Compilation No. 82
Compilation date: 1 August 2019
Includes amendments up to: PB 58 of 2019
Registered: 16 August 2019
This compilation is in 6 volumes
Volume 1: sections 1–26 and Schedule 1 (A–C)
Volume 2: Schedule 1 (D–K)
Volume 3: Schedule 1 (L–P)
Volume 4: Schedule 1 (Q–Z), Schedules 2 and 3
Volume 5: Schedule 4 (Part 1: A–R)
Volume 6: Schedule 4 (Part 1: S–Z, Part 3), Schedule 5 and
Endnotes
Each volume has its own contents
About this compilation
This compilation
This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012) that shows the text of the law as amended and in force on 1 August 2019 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
Schedule 1—Ready‑prepared pharmaceutical benefits
Schedule 1—Ready‑prepared pharmaceutical benefits
(sections 5 to 10, 16 to 18, 20, 21, 23 to 26)
Listed Drug | Form | Manner of Administration | Schedule Equivalent | Brand | Responsible Person | Authorised Prescriber | Circumstances | Purposes | Maximum Quantity | Number of Repeats | Pack Quantity | Determined Quantity | Section 100/ Prescriber Bag only |
Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | a | Presolol 100 | AF | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Trandate | QA | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet containing labetalol hydrochloride 200 mg | Oral | a | Presolol 200 | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Trandate | QA | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Lacosamide | Oral solution 10 mg per mL, 200 mL | Oral |
| Vimpat | UC | MP NP | C8770 C8815 |
| 6 | 5 | 1 |
|
|
| Tablet 50 mg | Oral |
| Vimpat | UC | MP NP | C8813 C8815 | P8813 | 14 | 1 | 14 |
|
|
|
|
|
|
|
| MP NP | C8813 C8815 | P8815 | 56 | 5 | 14 |
|
|
| Tablet 100 mg | Oral |
| Vimpat | UC | MP NP | C8770 C8813 C8815 | P8813 | 14 | 1 | 14 |
|
|
|
|
|
|
|
| MP NP | C8770 C8813 C8815 | P8770 P8815 | 56 | 5 | 56 |
|
|
| Tablet 150 mg | Oral |
| Vimpat | UC | MP NP | C8770 C8813 C8815 | P8813 | 14 | 1 | 14 |
|
|
|
|
|
|
|
| MP NP | C8770 C8813 C8815 | P8770 P8815 | 56 | 5 | 56 |
|
|
| Tablet 200 mg | Oral |
| Vimpat | UC | MP NP | C8770 C8815 |
| 56 | 5 | 56 |
|
|
Lamivudine | Oral solution 10 mg per mL, 240 mL | Oral |
| 3TC | VI | MP | C4454 C4512 |
| 8 | 5 | 1 |
| D(100) |
Tablet 100 mg | Oral | a | Zeffix | RW | MP | C4993 C5036 |
| 56 | 5 | 28 |
| D(100) | |
a | Zetlam | AF | MP | C4993 C5036 |
| 56 | 5 | 28 |
| D(100) | |||
Tablet 150 mg | Oral | a | 3TC | VI | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |
a | Lamivudine Alphapharm | AF | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |||
Tablet 300 mg | Oral | a | 3TC | VI | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) | |
a | Lamivudine Alphapharm | AF | MP | C4454 C4512 |
| 60 | 5 | 30 |
| D(100) | |||
Lamivudine with zidovudine | Tablet 150 mg-300 mg | Oral | a | Combivir | VI | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) |
a | Lamivudine 150 mg + Zidovudine 300 mg Alphapharm | AF | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |||
Lamotrigine | Tablet 5 mg | Oral | a | Lamictal | AS | MP NP | C5138 |
| 56 | 5 | 56 |
|
|
a | Lamotrigine Aspen 5 | RW | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
Tablet 25 mg | Oral | a | APO-Lamotrigine | TX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |
a | Lamictal | AS | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | LAMITAN | RF | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine AN | EA | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Aspen 25 | RW | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine GH | GQ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Sandoz | SZ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Logem | AL | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Reedos 25 | DO | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Sandoz Lamotrigine | HX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
Tablet 50 mg | Oral | a | APO-Lamotrigine | TX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |
a | Lamictal | AS | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | LAMITAN | RF | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine AN | EA | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Aspen 50 | RW | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine GH | GQ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Sandoz | SZ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Logem | AL | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Reedos 50 | DO | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Sandoz Lamotrigine | HX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
Tablet 100 mg | Oral | a | APO-Lamotrigine | TX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |
a | Lamictal | AS | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | LAMITAN | RF | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine AN | EA | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Aspen 100 | RW | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine GH | GQ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Sandoz | SZ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Logem | AL | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Reedos 100 | DO | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
|
| a | Sandoz Lamotrigine | HX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |
Tablet 200 mg | Oral | a | APO-Lamotrigine | TX | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |
a | Lamictal | AS | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | LAMITAN | RF | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine AN | EA | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Aspen 200 | RW | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine GH | GQ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Lamotrigine Sandoz | SZ | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Logem | AL | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
a | Reedos 200 | DO | MP NP | C5138 |
| 56 | 5 | 56 |
|
| |||
|
|
| a | Sandoz Lamotrigine | HX | MP NP | C5138 |
| 56 | 5 | 56 |
|
|
Lanreotide | Injection 60 mg (as acetate) in single dose pre-filled syringe | Injection |
| Somatuline Autogel | IS | MP | C4569 C4575 C7025 C7041 C7509 C7532 |
| 2 | 5 | 1 |
| D(100) |
Injection 90 mg (as acetate) in single dose pre-filled syringe | Injection |
| Somatuline Autogel | IS | MP | C4569 C4575 C7025 C7041 C7509 C7532 |
| 2 | 5 | 1 |
| D(100) | |
Injection 120 mg (as acetate) in single dose pre-filled syringe | Injection |
| Somatuline Autogel | IS | MP | C4569 C4575 C7025 C7041 C7509 C7532 C8260 C8261 C9161 |
| 2 | 5 | 1 |
| D(100) | |
Powder for suspension for injection 30 mg (as acetate) with diluent | Injection |
| Somatuline LA | IS | MP | C7042 C7063 |
| 2 | 11 | 1 |
| D(100) | |
Lansoprazole | Capsule 15 mg | Oral |
| Zopral | AF | MP NP | C5444 C5512 |
| 30 | 5 | 30 |
|
|
Capsule 30 mg | Oral |
| APO-Lansoprazole | TX | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |
| Lanzopran | RA | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |||
| Zopral | AF | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |||
| APO-Lansoprazole | TX | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
| Lanzopran | RA | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
| Zopral | AF | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
Tablet 15 mg (orally disintegrating) | Oral | a | APO-Lansoprazole ODT | TX | MP NP | C5444 C5512 |
| 28 | 5 | 28 |
|
| |
a | Lansoprazole ODT GH | GQ | MP NP | C5444 C5512 |
| 28 | 5 | 28 |
|
| |||
a | Zopral ODT | AF | MP NP | C5444 C5512 |
| 28 | 5 | 28 |
|
| |||
a | Zoton FasTabs | PF | MP NP | C5444 C5512 |
| 28 | 5 | 28 |
|
| |||
Tablet 30 mg (orally disintegrating) | Oral |
| APO-Lansoprazole ODT | TX | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |
| Lansoprazole ODT GH | GQ | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |||
| Zopral ODT | AF | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |||
| Zoton FasTabs | PF | MP NP | C8774 C8775 C8776 C8780 | P8774 P8775 | 28 | 1 | 28 |
|
| |||
| APO-Lansoprazole ODT | TX | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
| Lansoprazole ODT GH | GQ | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
| Zopral ODT | AF | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
| Zoton FasTabs | PF | MP NP | C8774 C8775 C8776 C8780 | P8776 P8780 | 28 | 5 | 28 |
|
| |||
Lanthanum | Tablet, chewable, 500 mg (as carbonate hydrate) | Oral |
| Fosrenol | ZI | MP NP | C5491 |
| 90 | 5 | 90 |
|
|
MP | C5454 C5530 |
| 180 | 5 | 90 |
| C(100) | ||||||
Tablet, chewable, 750 mg (as carbonate hydrate) | Oral |
| Fosrenol | ZI | MP NP | C5491 |
| 90 | 5 | 90 |
|
| |
MP | C5454 C5530 |
| 180 | 5 | 90 |
| C(100) | ||||||
Tablet, chewable, 1000 mg (as carbonate hydrate) | Oral |
| Fosrenol | ZI | MP NP | C5491 |
| 90 | 5 | 90 |
|
| |
MP | C5454 C5530 |
| 180 | 5 | 90 |
| C(100) | ||||||
Lapatinib | Tablet 250 mg (as ditosilate monohydrate) | Oral |
| Tykerb | NV | MP | C6105 C7441 |
| 140 | 2 | 70 |
|
|
Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye | a | APO-Latanoprost | TX | AO MP |
|
| 1 | 5 | 1 |
|
|
a | Lanpro | JU | AO MP |
|
| 1 | 5 | 1 |
|
| |||
a | Latanoprost Actavis | EA | AO MP |
|
| 1 | 5 | 1 |
|
| |||
a | Latanoprost Sandoz | SZ | AO MP |
|
| 1 | 5 | 1 |
|
| |||
a | Xalaprost | QA | AO MP |
|
| 1 | 5 | 1 |
|
| |||
a | Xalatan | PF | AO MP |
|
| 1 | 5 | 1 |
|
| |||
Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | a | APO-Latanoprost/Timolol 0.05/5 | TX | AO | C5038 |
| 1 | 5 | 1 |
|
|
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Lantim | JU | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Latanoprost/timolol AN 50/5 | JO | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Latanoprost/Timolol Sandoz 50/5 | SZ | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Xalacom | PF | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
a | Xalamol 50/5 | QA | AO | C5038 |
| 1 | 5 | 1 |
|
| |||
MP | C4343 |
| 1 | 5 | 1 |
|
| ||||||
Ledipasvir with sofosbuvir | Tablet containing 90 mg ledipasvir with 400 mg sofosbuvir | Oral |
| Harvoni | GI | MP NP | C5944 C5969 C5972 | P5944 | 28 | 1 | 28 |
|
|
MP NP | C5944 C5969 C5972 | P5969 | 28 | 2 | 28 |
|
| ||||||
MP NP | C5944 C5969 C5972 | P5972 | 28 | 5 | 28 |
|
| ||||||
Leflunomide | Tablet 10 mg | Oral | a | Arabloc | AV | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
|
a | Arava | SW | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Ataris 10 | AF | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide AN | EA | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide APOTEX | GX | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide generichealth | HQ | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide GH | GQ | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide Sandoz | SZ | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Lunava 10 | ZP | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
Tablet 20 mg | Oral | a | Arabloc | AV | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |
a | Arava | SW | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Ataris 20 | AF | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide AN | EA | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide APOTEX | GX | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide generichealth | HQ | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide GH | GQ | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
a | Leflunomide Sandoz | SZ | MP | C5681 C5766 |
| 30 | 5 | 30 |
|
| |||
a | Lunava 20 | ZP | MP | C5681 |
| 30 | 5 | 30 |
|
| |||
Lenalidomide | Capsule 5 mg | Oral |
| Revlimid | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) |
Capsule 10 mg | Oral |
| Revlimid | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) | |
Capsule 15 mg | Oral |
| Revlimid | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) | |
Capsule 25 mg | Oral |
| Revlimid | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) | |
Lenograstim | Powder for injection 13,400,000 I.U. (105 micrograms) | Injection |
| Granocyte 13 | PF | MP | C6488 C6490 C6494 C6502 C6507 C6512 C6516 C6521 C6522 C6523 C6532 C6535 C6543 C6546 C6622 C6623 C6633 C6634 C6644 C6649 C6653 C6654 C6656 C6657 C6663 C6673 C6681 C6682 |
| 20 | 11 | 1 |
| D(100) |
Powder for injection 33,600,000 I.U. (263 micrograms) | Injection |
| Granocyte 34 | PF | MP | C6488 C6490 C6494 C6502 C6507 C6512 C6516 C6521 C6522 C6523 C6532 C6535 C6543 C6546 C6622 C6623 C6633 C6634 C6644 C6649 C6653 C6654 C6656 C6657 C6663 C6673 C6681 C6682 |
| 20 | 11 | 1 |
| D(100) | |
Lenvatinib | Capsule 4 mg (as mesilate) | Oral |
| Lenvima | EI | MP | C6578 C6604 C8584 C8593 C8618 | P6578 P6604 | 30 | 2 | 30 |
|
|
|
|
|
|
|
| MP | C6578 C6604 C8584 C8593 C8618 | P8584 P8593 P8618 | 90 | 2 | 30 |
|
|
| Capsule 10 mg (as mesilate) | Oral |
| Lenvima | EI | MP | C6578 C6604 |
| 60 | 2 | 30 |
|
|
Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral | a | APO-Lercanidipine | TX | MP NP |
|
| 28 | 5 | 28 |
|
|
a | Blooms the Chemist Lercanidipine | IB | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | BTC Lercanidipine | JB | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercadip | EA | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercan | RW | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercanidipine APOTEX | GX | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercanidipine Sandoz | SZ | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Zanidip | GO | MP NP |
|
| 28 | 5 | 28 |
|
| |||
|
| a | Zircol 10 | AL | MP NP |
|
| 28 | 5 | 28 |
|
| |
Tablet containing lercanidipine hydrochloride 20 mg | Oral | a | APO-Lercanidipine | TX | MP NP |
|
| 28 | 5 | 28 |
|
| |
a | Blooms the Chemist Lercanidipine | IB | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | BTC Lercanidipine | JB | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercadip | EA | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercan | RW | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercanidipine APOTEX | GX | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Lercanidipine Sandoz | SZ | MP NP |
|
| 28 | 5 | 28 |
|
| |||
a | Zanidip | GO | MP NP |
|
| 28 | 5 | 28 |
|
| |||
|
|
| a | Zircol 20 | AL | MP NP |
|
| 28 | 5 | 28 |
|
|
Lercanidipine with enalapril | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg | Oral |
| Zan-Extra 10/10 | GO | MP NP | C4398 |
| 28 | 5 | 28 |
|
|
Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg | Oral |
| Zan-Extra 10/20 | GO | MP NP | C4398 |
| 28 | 5 | 28 |
|
| |
Letrozole | Tablet 2.5 mg | Oral | a | APO-Letrozole | TX | MP NP | C5464 |
| 30 | 5 | 30 |
|
|
a | Femara 2.5 mg | NV | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Femolet | AF | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Fera | QA | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Gynotril | ER | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Letroz | JU | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Letrozole AN | JO | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Letrozole FBM | FO | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Letrozole generichealth | GQ | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Letrozole Sandoz | SZ | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Letrozole 2.5 | CR | MP NP | C5464 |
| 30 | 5 | 30 |
|
| |||
Leuprorelin | I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe | Injection |
| Lucrin Depot Paediatric 30 mg PDS | VE | MP | C6422 C6425 C6426 |
| 1 | 1 | 1 |
|
|
I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre-filled dual-chamber syringe | Injection |
| Lucrin Depot 7.5mg PDS | VE | MP | C6409 |
| 1 | 5 | 1 |
|
| |
I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre-filled dual-chamber syringe | Injection |
| Lucrin Depot 3 Month PDS | VE | MP | C6409 |
| 1 | 1 | 1 |
|
| |
I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe | Injection |
| Lucrin Depot 4 Month PDS | VE | MP | C6409 |
| 1 | 1 | 1 |
|
| |
I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre-filled dual-chamber syringe | Injection |
| Lucrin Depot 6-Month | VE | MP | C6409 |
| 1 | 0 | 1 |
|
| |
Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set | Injection |
| Eligard 1 month | MF | MP | C6409 |
| 1 | 5 | 1 |
|
| |
Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set | Injection |
| Eligard 3 month | MF | MP | C6409 |
| 1 | 1 | 1 |
|
| |
Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set | Injection |
| Eligard 4 month | MF | MP | C6409 |
| 1 | 1 | 1 |
|
| |
Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set | Injection |
| Eligard 6 month | MF | MP | C6409 |
| 1 | 0 | 1 |
|
| |
Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
| Bi ELIGARD CP | MF | MP | C4895 |
| 1 | 5 | 1 |
|
|
Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
| Bi ELIGARD CP | MF | MP | C4895 |
| 1 | 0 | 1 |
|
| |
Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg | Injection/oral |
| Bi ELIGARD CP | MF | MP | C4895 |
| 1 | 1 | 1 |
|
| |
Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral | a | APO-Levetiracetam | TX | MP NP | C7620 |
| 1 | 5 | 1 |
|
|
a | Keppra | UC | MP NP | C7620 |
| 1 | 5 | 1 |
|
| |||
a | Kerron | DO | MP NP | C7620 |
| 1 | 5 | 1 |
|
| |||
a | Levetiracetam-AFT | AE | MP NP | C7620 |
| 1 | 5 | 1 |
|
| |||
Tablet 250 mg | Oral | a | APO-Levetiracetam | TX | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |
a | Keppra | UC | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kerron 250 | DO | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kevtam 250 | AF | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levactam | ER | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levecetam 250 | RZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam AN | EA | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam GH | GQ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam SZ | SZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levi 250 | RW | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
Tablet 500 mg | Oral | a | APO-Levetiracetam | TX | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |
a | Keppra | UC | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kerron 500 | DO | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kevtam 500 | AF | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levactam | ER | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levecetam 500 | RZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam AN | EA | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam GH | GQ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam SZ | SZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levi 500 | RW | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
Tablet 1 g | Oral | a | APO-Levetiracetam | TX | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |
a | Keppra | UC | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kerron 1000 | DO | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Kevtam 1000 | AF | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levactam | ER | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levecetam 1000 | RZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam AN | EA | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam GH | GQ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levetiracetam SZ | SZ | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
a | Levi 1000 | RW | MP NP | C7603 |
| 60 | 5 | 60 |
|
| |||
Levodopa with benserazide | Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| Madopar 62.5 | RO | MP NP |
|
| 100 | 5 | 100 |
|
|
Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Madopar 125 | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release) | Oral |
| Madopar HBS | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
| Madopar | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| Madopar Rapid 62.5 | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Madopar Rapid 125 | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Madopar 125 | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
| Madopar | RO | MP NP |
|
| 100 | 5 | 100 |
|
| |
Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | Intra-intestinal |
| Duodopa | VE | MP NP | C5473 |
| 56 | 5 | 7 |
|
|
MP | C6863 C6880 |
| 56 | 5 | 7 |
| C(100) | ||||||
Tablet 100 mg-25 mg (as monohydrate) | Oral | a | Kinson | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Sinemet 100/25 | MK | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet (modified release) 200 mg-50 mg | Oral |
| Carbidopa and Levodopa Extended-release Tablets | DZ | MP NP | C5253 |
| 100 | 5 | 100 |
|
| |
Tablet (modified release) 200 mg-50 mg (as monohydrate) | Oral |
| Sinemet CR | MK | MP NP | C5253 |
| 100 | 5 | 100 |
|
| |
Tablet 250 mg-25 mg (as monohydrate) | Oral |
| Sinemet | MK | MP NP |
|
| 100 | 5 | 100 |
|
| |
| Tablet 250 mg-25 mg (USP) | Oral |
| Carbidopa and Levodopa Tablets, USP | DZ | MP NP |
|
| 100 | 5 | 100 |
|
|
Levodopa with carbidopa and entacapone | Tablet 50 mg-12.5 mg (as monohydrate)-200 mg | Oral |
| Stalevo 50/12.5/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
|
Tablet 75 mg-18.75 mg (as monohydrate)-200 mg | Oral |
| Stalevo 75/18.75/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
| |
Tablet 100 mg-25 mg (as monohydrate)-200 mg | Oral |
| Stalevo 100/25/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
| |
Tablet 125 mg-31.25 mg (as monohydrate)-200 mg | Oral |
| Stalevo 125/31.25/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
| |
Tablet 150 mg-37.5 mg (as monohydrate)-200 mg | Oral |
| Stalevo 150/37.5/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
| |
Tablet 200 mg-50 mg (as monohydrate)-200 mg | Oral |
| Stalevo 200/50/200mg | NV | MP NP | C5212 C5288 |
| 200 | 4 | 100 |
|
| |
Levonorgestrel | Intrauterine drug delivery system 52 mg | intrauterine |
| Mirena | BN | MP NP | C5135 C5214 C5289 |
| 1 | 0 | 1 |
|
|
Tablets 30 micrograms, 28 | Oral |
| Microlut 28 | BN | MP NP MW |
|
| 4 | 2 | 4 |
|
| |
Levonorgestrel with ethinylestradiol | Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | Oral | b | Logynon ED | SY | MP NP |
|
| 4 | 2 | 4 |
|
|
a | Trifeme 28 | FZ | MP NP |
|
| 4 | 2 | 4 |
|
| |||
a | Triphasil 28 | PF | MP NP |
|
| 4 | 2 | 4 |
|
| |||
b | Triquilar ED | BN | MP NP |
|
| 4 | 2 | 4 |
|
| |||
Pack containing 21 tablets 100 micrograms-20 micrograms and 7 inert tablets | Oral |
| Femme-Tab ED 20/100 | AE | MP NP |
|
| 4 | 2 | 4 |
|
| |
Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets | Oral |
| Microgynon 50 ED | BN | MP NP |
|
| 4 | 2 | 4 |
|
| |
Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets | Oral | b | Eleanor 150/30 ED | EA | MP NP |
|
| 4 | 2 | 4 |
|
| |
b | Evelyn 150/30 ED | GQ | MP NP |
|
| 4 | 2 | 4 |
|
| |||
b | Femme-Tab ED 30/150 | AE | MP NP |
|
| 4 | 2 | 4 |
|
| |||
b | Lenest 30 ED | AF | MP NP |
|
| 4 | 2 | 4 |
|
| |||
b | Levlen ED | SY | MP NP |
|
| 4 | 2 | 4 |
|
| |||
b | Micronelle 30 ED | TX | MP NP |
|
| 4 | 2 | 4 |
|
| |||
a | Monofeme 28 | FZ | MP NP |
|
| 4 | 2 | 4 |
|
| |||
a | Nordette 28 | PF | MP NP |
|
| 4 | 2 | 4 |
|
| |||
Levothyroxine | Tablet containing 50 micrograms anhydrous levothyroxine sodium | Oral | a | Eutroxsig | FM | MP NP |
|
| 200 | 1 | 200 |
|
|
a | Oroxine | QA | MP NP |
|
| 200 | 1 | 200 |
|
| |||
Tablet containing 75 micrograms anhydrous levothyroxine sodium | Oral | a | Eutroxsig | FM | MP NP |
|
| 200 | 1 | 200 |
|
| |
a | Oroxine | QA | MP NP |
|
| 200 | 1 | 200 |
|
| |||
Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral | a | Eutroxsig | FM | MP NP |
|
| 200 | 1 | 200 |
|
| |
a | Oroxine | QA | MP NP |
|
| 200 | 1 | 200 |
|
| |||
Tablet containing 200 micrograms anhydrous levothyroxine sodium | Oral | a | Eutroxsig | FM | MP NP |
|
| 200 | 1 | 200 |
|
| |
a | Oroxine | QA | MP NP |
|
| 200 | 1 | 200 |
|
| |||
Lidocaine | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | Injection |
| Xylocard 500 | AS | MP NP |
|
| 10 | 0 | 10 |
|
|
Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | Injection |
| Pfizer Australia Pty Ltd | PF | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 5 | 5 | PB(MP) | |
Linagliptin | Tablet 5 mg | Oral |
| Trajenta | BY | MP | C6346 C6363 C6376 C7505 C7541 |
| 30 | 5 | 30 |
|
|
NP | C6346 C6363 C6376 C7505 |
| 30 | 5 | 30 |
|
| ||||||
Linagliptin with metformin | Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride | Oral |
| Trajentamet | BY | MP | C6333 C6336 C6344 C6443 C7507 C7530 |
| 60 | 5 | 60 |
|
|
NP | C6333 C6336 C6344 C6443 C7530 |
| 60 | 5 | 60 |
|
| ||||||
Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride | Oral |
| Trajentamet | BY | MP | C6333 C6336 C6344 C6443 C7507 C7530 |
| 60 | 5 | 60 |
|
| |
NP | C6333 C6336 C6344 C6443 C7530 |
| 60 | 5 | 60 |
|
| ||||||
Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride | Oral |
| Trajentamet | BY | MP | C6333 C6336 C6344 C6443 C7507 C7530 |
| 60 | 5 | 60 |
|
| |
NP | C6333 C6336 C6344 C6443 C7530 |
| 60 | 5 | 60 |
|
| ||||||
Lincomycin | Injection 600 mg (as hydrochloride monohydrate) in 2 mL | Injection | a | Lincocin | PF | MP NP MW PDP |
|
| 5 | 0 | 5 |
|
|
a | LINCOMYCIN SXP | XC | PDP MP NP MW |
|
| 5 | 0 | 5 |
|
| |||
Liothyronine | Tablet containing liothyronine sodium 20 micrograms | Oral |
| Tertroxin | QA | MP NP | C6382 C6410 C6475 |
| 100 | 2 | 100 |
|
|
Lipegfilgrastim | Injection 6 mg in 0.6 mL single use pre-filled syringe | Injection |
| Lonquex | TB | MP | C7822 C7823 C7843 C7862 |
| 1 | 11 | 1 |
| D(100) |
Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 30 mg | Oral |
| Vyvanse | ZI | MP NP | C5252 |
| 30 | 5 | 30 |
|
|
Capsule containing lisdexamfetamine dimesilate 50 mg | Oral |
| Vyvanse | ZI | MP NP | C5252 |
| 30 | 5 | 30 |
|
| |
Capsule containing lisdexamfetamine dimesilate 70 mg | Oral |
| Vyvanse | ZI | MP NP | C5252 |
| 30 | 5 | 30 |
|
| |
Lisinopril | Tablet 5 mg | Oral | a | APO-Lisinopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Auro-Lisinopril 5 | DO | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Fibsol 5 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zestril | AP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zinopril 5 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 10 mg | Oral | a | APO-Lisinopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Auro-Lisinopril 10 | DO | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Fibsol 10 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zestril | AP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zinopril 10 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 20 mg | Oral | a | APO-Lisinopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Auro-Lisinopril 20 | DO | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Fibsol 20 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lisinopril Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zestril | AP | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Zinopril 20 | AL | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Lithium | Tablet containing lithium carbonate 250 mg | Oral |
| Lithicarb | AS | MP NP |
|
| 200 | 2 | 200 |
|
|
Tablet containing lithium carbonate 450 mg (slow release) | Oral |
| Quilonum SR | AS | MP NP |
|
| 200 | 2 | 100 |
|
| |
Loperamide | Capsule containing loperamide hydrochloride 2 mg | Oral | a | Gastrex | CR | MP NP | C6343 C6364 | P6364 | 12 | 0 | 12 |
|
|
a | Gastro-Stop | AS | MP NP | C6343 C6364 | P6364 | 12 | 0 | 12 |
|
| |||
a | Gastrex | CR | MP NP | C6343 C6364 | P6343 | 60 | 0 | 12 |
|
| |||
a | Gastro-Stop | AS | MP NP | C6343 C6364 | P6343 | 60 | 0 | 12 |
|
| |||
Lopinavir with ritonavir | Oral liquid 400 mg-100 mg per 5 mL, 60 mL | Oral |
| Kaletra | VE | MP | C4454 C4512 |
| 10 | 5 | 1 |
| D(100) |
Tablet 100 mg-25 mg | Oral |
| Kaletra | VE | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |
Tablet 200 mg-50 mg | Oral |
| Kaletra | VE | MP | C4454 C4512 |
| 240 | 5 | 120 |
| D(100) | |
Losartan | Tablet containing losartan potassium 25 mg | Oral |
| Cozavan | AF | MP NP |
|
| 30 | 5 | 30 |
|
|
Tablet containing losartan potassium 50 mg | Oral |
| Cozavan | AF | MP NP |
|
| 60 | 5 | 30 |
|
| |
Lumacaftor with ivacaftor | Tablet containing lumacaftor 100 mg with ivacaftor 125 mg | Oral |
| Orkambi | VR | MP | See Note 3 |
| See Note 3 | See Note 3 | 112 |
| D(100) |
Tablet containing lumacaftor 200 mg with ivacaftor 125 mg | Oral |
| Orkambi | VR | MP | See Note 3 |
| See Note 3 | See Note 3 | 112 |
| D(100) | |
Lurasidone | Tablet containing lurasidone hydrochloride 40 mg | Oral |
| Latuda | SE | MP NP | C4246 |
| 30 | 5 | 30 |
|
|
Tablet containing lurasidone hydrochloride 80 mg | Oral |
| Latuda | SE | MP NP | C4246 |
| 30 | 5 | 30 |
|
| |
Lutropin alfa | Powder for injection 75 I.U. with solvent | Injection |
| Luveris | SG | MP | C5251 |
| 14 | 0 | 1 |
| D(100) |
Macitentan | Tablet 10 mg | Oral |
| Opsumit | AT | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 30 |
| D(100) |
Macrogol 3350 | Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL | Oral |
| Movicol Liquid | NE | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P6171 | 2 | 3 | 1 |
|
|
MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 2 | 5 | 1 |
|
| ||||||
Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral | a | APO-MACROGOL plus ELECTROLYTES | TX | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |
a | Chemists' Own Macrogol with Electrolytes | RW | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | lax-sachets | AE | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | LaxaCon | EA | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | Macrovic | RF | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | Molaxole | GO | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | Movicol | NE | MP NP | C4576 C4577 C4580 C4596 C4601 C6171 | P4576 P4577 P4580 P4596 P4601 | 1 | 5 | 1 |
|
| |||
a | APO-MACROGOL plus ELECTROLYTES | TX | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | Chemists' Own Macrogol with Electrolytes | RW | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | lax-sachets | AE | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | LaxaCon | EA | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | Macrovic | RF | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | Molaxole | GO | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | Movicol | NE | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | APO-MACROGOL plus ELECTROLYTES | TX | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | Chemists' Own Macrogol with Electrolytes | RW | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | lax-sachets | AE | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | LaxaCon | EA | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | Macrovic | RF | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | Molaxole | GO | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
a | Movicol | NE | MP NP |
| P6171 | 2 | 3 | 1 |
|
| |||
Powder for oral solution 510 g | Oral |
| OsmoLax | KY | MP | See Note 2 | See Note 2 | See Note 2 | See Note 2 | 1 |
| C(100) | |
MP NP | C4171 C4173 C4177 C4179 C4180 C6170 | P4171 P4173 P4177 P4179 P4180 | 1 | 5 | 1 |
|
| ||||||
MP NP |
| P6170 | 2 | 3 | 1 |
|
| ||||||
Sachets containing powder for oral solution 17 g, 30 | Oral |
| Herron ClearLax | ON | MP NP | C4171 C4173 C4177 C4179 C4180 C6170 | P4171 P4173 P4177 P4179 P4180 | 1 | 5 | 1 |
|
| |
MP NP | C4171 C4173 C4177 C4179 C4180 C6170 | P6170 | 2 | 3 | 1 |
|
| ||||||
Magnesium | Tablet 37.4 mg (as aspartate dihydrate) | Oral |
| Mag-Sup | PP | MP NP | C5466 C5506 |
| 50 | 5 | 50 |
|
|
| MagMin (PBS) | BB | MP NP | C5466 C5506 |
| 50 | 5 | 50 |
|
| |||
Mannitol | Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers | Inhalation by mouth |
| bronchitol | XA | MP | C7349 C7362 C7364 C7367 |
| 4 | 5 | 1 |
| D(100) |
Maraviroc | Tablet 150 mg | Oral |
| Celsentri | VI | MP | C5008 |
| 120 | 5 | 60 |
| D(100) |
Tablet 300 mg | Oral |
| Celsentri | VI | MP | C5008 |
| 120 | 5 | 60 |
| D(100) | |
Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | a | Depo-Provera | PF | MP NP |
|
| 1 | 1 | 1 |
|
|
a | Depo-Ralovera | FZ | MP NP |
|
| 1 | 1 | 1 |
|
| |||
Tablet containing medroxyprogesterone acetate 5 mg | Oral | a | Provera | PF | MP NP |
|
| 56 | 2 | 56 |
|
| |
a | Ralovera | FZ | MP NP |
|
| 56 | 2 | 56 |
|
| |||
Tablet containing medroxyprogesterone acetate 10 mg | Oral | a | Provera | PF | MP NP |
|
| 30 | 2 | 30 |
|
| |
a | Ralovera | FZ | MP NP |
|
| 30 | 2 | 30 |
|
| |||
a | Provera | PF | MP |
| P6244 | 100 | 2 | 100 |
|
| |||
a | Ralovera | FZ | MP |
| P6244 | 100 | 2 | 100 |
|
| |||
Tablet containing medroxyprogesterone acetate 100 mg | Oral |
| Provera | PF | MP | C5649 C5791 |
| 100 | 2 | 100 |
|
| |
Tablet containing medroxyprogesterone acetate 200 mg | Oral |
| Provera | PF | MP | C5649 C5791 |
| 60 | 2 | 60 |
|
| |
Tablet containing medroxyprogesterone acetate 250 mg | Oral |
| Provera | PF | MP | C5649 C5791 |
| 60 | 2 | 60 |
|
| |
Tablet containing medroxyprogesterone acetate 500 mg | Oral |
| Provera | PF | MP | C5731 |
| 30 | 2 | 30 |
|
| |
Mefenamic acid | Capsule 250 mg | Oral |
| Ponstan | PF | MP NP | C6213 C6229 |
| 50 | 2 | 50 |
|
|
Meloxicam | Capsule 7.5 mg | Oral |
| APO-Meloxicam | TX | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
|
| Chem mart Meloxicam | CH | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam Sandoz | SZ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Mobic | BY | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Movalis 7.5 | RW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Moxicam | AF | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Terry White Chemists Meloxicam | TW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
Capsule 15 mg | Oral |
| APO-Meloxicam | TX | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |
| Chem mart Meloxicam | CH | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam Sandoz | SZ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Mobic | BY | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Movalis 15 | RW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Moxicam | AF | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Terry White Chemists Meloxicam | TW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
Tablet 7.5 mg | Oral |
| APO-Meloxicam | TX | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |
| Chem mart Meloxicam 7.5 mg | CH | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| CIPLA MELOXICAM 7.5 | LR | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxiauro 7.5 | DO | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxibell | GQ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam AN | EA | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam Sandoz | SZ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam-GA | ED | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Mobic | BY | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Movalis 7.5 | RW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Moxicam 7.5 | AF | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Pharmacor Meloxicam 7.5 | CR | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Terry White Chemists Meloxicam 7.5 mg | TW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
Tablet 15 mg | Oral |
| APO-Meloxicam | TX | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |
| Chem mart Meloxicam 15 mg | CH | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| CIPLA MELOXICAM 15 | LR | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxiauro 15 | DO | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxibell | GQ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam AN | EA | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam Sandoz | SZ | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Meloxicam-GA | ED | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Mobic | BY | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Movalis 15 | RW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Moxicam 15 | AF | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Pharmacor Meloxicam 15 | CR | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
| Terry White Chemists Meloxicam 15 mg | TW | MP NP | C4907 C4962 |
| 30 | 3 | 30 |
|
| |||
Melphalan | Tablet 2 mg | Oral |
| Alkeran | AS | MP |
|
| 25 | 1 | 25 |
|
|
Memantine | Tablet containing memantine hydrochloride 10 mg | Oral | a | APO-Memantine | TX | MP NP | C4214 C4218 C4221 |
| 56 | 5 | 56 |
|
|
a | Ebixa | LU | MP NP | C4214 C4218 C4221 |
| 56 | 5 | 56 |
|
| |||
a | Memantine generichealth | GQ | MP NP | C4214 C4218 C4221 |
| 56 | 5 | 56 |
|
| |||
a | Memanxa | RW | MP NP | C4214 C4218 C4221 |
| 56 | 5 | 56 |
|
| |||
Tablet containing memantine hydrochloride 20 mg | Oral | a | APO-Memantine | TX | MP NP | C4214 C4218 C4221 |
| 28 | 5 | 28 |
|
| |
a | Ebixa | LU | MP NP | C4214 C4218 C4221 |
| 28 | 5 | 28 |
|
| |||
a | Memantine generichealth | GQ | MP NP | C4214 C4218 C4221 |
| 28 | 5 | 28 |
|
| |||
Mepolizumab | Powder for injection 100 mg | Injection |
| Nucala | GK | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL | Oral |
| Allmercap | LM | MP |
|
| 1 | 2 | 1 |
|
|
Tablet containing mercaptopurine monohydrate 50 mg | Oral |
| Purinethol | AS | MP |
|
| 100 | 2 | 25 |
|
| |
Mesalazine | Enemas 1 g in 100 mL, 7 | Rectal |
| Pentasa | FP | MP NP | C4888 |
| 4 | 1 | 1 |
|
|
Enemas 2 g in 60 mL, 7 | Rectal |
| Salofalk | OA | MP NP | C4888 |
| 4 | 1 | 1 |
|
| |
Enemas 4 g in 60 mL, 7 | Rectal |
| Salofalk | OA | MP NP | C4888 |
| 4 | 1 | 1 |
|
| |
Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | Rectal |
| Salofalk | OA | MP NP | C4888 |
| 4 | 1 | 1 |
|
| |
Sachet containing granules, 500 mg per sachet | Oral |
| Salofalk | OA | MP NP | C4824 |
| 200 | 5 | 100 |
|
| |
Sachet containing granules, 1 g per sachet | Oral |
| Salofalk | OA | MP NP | C4824 |
| 100 | 5 | 100 |
|
| |
Sachet containing prolonged release granules, 1 g per sachet | Oral |
| Pentasa | FP | MP NP | C4873 C4896 |
| 120 | 5 | 120 |
|
| |
Sachet containing granules, 1.5 g per sachet | Oral |
| Salofalk | OA | MP NP | C4824 |
| 60 | 5 | 60 |
|
| |
Sachet containing prolonged release granules, 2 g per sachet | Oral |
| Pentasa | FP | MP NP | C4873 C4896 |
| 60 | 5 | 60 |
|
| |
Sachet containing granules, 3 g per sachet | Oral |
| Salofalk | OA | MP NP | C4824 |
| 30 | 5 | 30 |
|
| |
Sachet containing prolonged release granules, 4 g per sachet | Oral |
| Pentasa | FP | MP NP | C4824 |
| 30 | 5 | 30 |
|
| |
Suppository (moulded) 1 g | Rectal |
| Salofalk | OA | MP NP | C4878 |
| 30 | 1 | 30 |
|
| |
Suppository 1 g | Rectal |
| Pentasa | FP | MP NP | C4878 |
| 30 | 1 | 30 |
|
| |
Tablet 250 mg (enteric coated) | Oral |
| Mesasal | AS | MP NP | C4873 C4896 |
| 100 | 5 | 100 |
|
| |
Tablet 500 mg (enteric coated) | Oral |
| Salofalk | OA | MP NP | C4873 C4896 |
| 200 | 5 | 100 |
|
| |
Tablet 500 mg (prolonged release) | Oral |
| Pentasa | FP | MP NP | C4873 C4896 |
| 200 | 5 | 100 |
|
| |
Tablet 800 mg (enteric coated) | Oral |
| Asacol | EU | MP NP | C4824 |
| 180 | 5 | 90 |
|
| |
Tablet 1 g (enteric coated) | Oral |
| Salofalk | OA | MP NP | C4873 C4896 |
| 120 | 5 | 60 |
|
| |
Tablet 1 g (prolonged release) | Oral |
| Pentasa | FP | MP NP | C4873 C4896 |
| 120 | 5 | 60 |
|
| |
Tablet 1.2 g (prolonged release) | Oral |
| Mezavant | ZI | MP NP | C4824 |
| 120 | 5 | 60 |
|
| |
Mesna | Solution for I.V. injection 400 mg in 4 mL ampoule | Injection |
| Uromitexan | BX | MP | C5106 |
| 15 | 5 | 15 |
|
|
MP | C5130 |
| 15 | 5 | 15 |
| C(100) | ||||||
Solution for I.V. injection 1 g in 10 mL ampoule | Injection |
| Uromitexan | BX | MP | C5106 |
| 15 | 5 | 15 |
|
| |
MP | C5130 |
| 15 | 5 | 15 |
| C(100) | ||||||
Metformin | Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | a | APO-Metformin XR 500 | TX | MP NP |
|
| 120 | 5 | 120 |
|
|
a | Blooms the Chemist Metformin XR 500 | IB | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Chem mart Metformin XR 500 | CH | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Diabex XR | AL | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Diaformin XR | AF | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Metex XR | RW | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Metformin XR 500 APOTEX | GX | MP NP |
|
| 120 | 5 | 120 |
|
| |||
a | Terry White Chemists Metformin XR 500 | TW | MP NP |
|
| 120 | 5 | 120 |
|
| |||
Tablet containing metformin hydrochloride 500 mg | Oral | a | APO-Metformin 500 | TX | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Chem mart Metformin | CH | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Diabex | AL | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Diaformin | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | FORMET 500 | RF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Glucobete 500 | DO | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Metformin AN | EA | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Metformin generichealth | GQ | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Metformin Sandoz | SZ | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Terry White Chemists Metformin | TW | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet containing metformin hydrochloride 850 mg | Oral | a | APO-Metformin 850 | TX | MP NP |
|
| 60 | 5 | 60 |
|
| |
a | Chem mart Metformin | CH | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Diabex 850 | AL | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Diaformin 850 | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | FORMET 850 | RF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Glucobete 850 | DO | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Metformin AN | EA | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Metformin Sandoz | SZ | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Terry White Chemists Metformin | TW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Tablet (extended release) containing metformin hydrochloride 1 g | Oral | a | APO-Metformin XR 1000 | TX | MP NP |
|
| 60 | 5 | 60 |
|
| |
a | Blooms the Chemist Metformin XR 1000 | IB | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Chem mart Metformin XR 1000 | CH | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Diabex XR 1000 | AL | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Diaformin XR 1000 | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | METEX XR | RF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | METEX XR 1000 | RW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Terry White Chemists Metformin XR 1000 | TW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Tablet containing metformin hydrochloride 1 g | Oral | a | APO-Metformin 1000 | TX | MP NP |
|
| 90 | 5 | 90 |
|
| |
a | Chem mart Metformin 1000 | CH | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Diabex 1000 | AL | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Diaformin 1000 | AF | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Formet 1000 | RW | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Glucobete 1000 | DO | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Metformin AN | EA | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Metformin generichealth 1000 | GQ | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Metformin GH | HQ | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Metformin Sandoz | SZ | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Sandoz Metformin | HX | MP NP |
|
| 90 | 5 | 90 |
|
| |||
a | Terry White Chemists Metformin 1000 | TW | MP NP |
|
| 90 | 5 | 90 |
|
| |||
Metformin with glibenclamide | Tablet containing metformin hydrochloride 250 mg with glibenclamide 1.25 mg | Oral |
| Glucovance 250mg/1.25mg | AL | MP NP |
|
| 90 | 5 | 90 |
|
|
Tablet containing metformin hydrochloride 500 mg with glibenclamide 2.5 mg | Oral |
| Glucovance 500mg/2.5mg | AL | MP NP |
|
| 90 | 5 | 90 |
|
| |
Tablet containing metformin hydrochloride 500 mg with glibenclamide 5 mg | Oral |
| Glucovance 500mg/5mg | AL | MP NP |
|
| 90 | 5 | 90 |
|
| |
Methadone | Injection containing methadone hydrochloride 10 mg in 1 mL | Injection |
| Physeptone | QA | MP NP | C4953 |
| 5 | 0 | 5 |
|
|
Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 1 L | Oral | a | Aspen Methadone Syrup | QA | MP NP | C6480 |
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
a | Biodone Forte | MW | MP NP | C6480 |
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL | Oral |
| Aspen Methadone Syrup | QA | MP NP | C4902 C4941 | P4941 | 1 | 0 | 1 |
|
| |
a | Aspen Methadone Syrup | QA | MP NP | C6480 |
| See Note 2 | See Note 2 | 1 |
| C(100) | |||
a | Biodone Forte | MW | MP NP | C6480 |
| See Note 2 | See Note 2 | 1 |
| C(100) | |||
| Aspen Methadone Syrup | QA | MP NP | C4902 C4941 | P4902 | 1 | 2 | 1 |
|
| |||
Tablet containing methadone hydrochloride 10 mg | Oral |
| Physeptone | QA | MP NP | C4953 |
| 20 | 0 | 20 |
|
| |
Methenamine | Tablet containing methenamine hippurate 1 g | Oral |
| Hiprex | IL | MP NP |
|
| 100 | 5 | 100 |
|
|
Methotrexate | Injection 5 mg in 2 mL vial | Injection |
| Hospira Pty Limited | PF | MP |
|
| 5 | 0 | 5 |
|
|
MP |
|
| See Note 2 | See Note 2 | 5 |
| C(100) | ||||||
MP |
| P6276 | See Note 2 | See Note 2 | 5 |
| C(100) | ||||||
Injection 7.5 mg in 0.15 mL pre-filled syringe | Injection |
| Trexject | LM | MP | C7488 C7518 |
| 4 | 5 | 1 |
|
| |
Injection 7.5 mg in 0.3 mL pre-filled syringe | Injection |
| Methoblastin PFS | PF | MP | C7488 C7518 |
| 4 | 5 | 4 |
|
| |
Injection 10 mg in 0.2 mL pre-filled syringe | Injection |
| Trexject | LM | MP | C7488 C7518 |
| 4 | 5 | 1 |
|
| |
Injection 10 mg in 0.4 mL pre-filled syringe | Injection |
| Methoblastin PFS | PF | MP | C7488 C7518 |
| 4 | 5 | 4 |
|
| |
Injection 15 mg in 0.3 mL pre-filled syringe | Injection |
| Trexject | LM | MP | C7488 C7518 |
| 4 | 5 | 1 |
|
| |
Injection 15 mg in 0.6 mL pre-filled syringe | Injection |
| Methoblastin PFS | PF | MP | C7488 C7518 |
| 4 | 5 | 4 |
|
| |
Injection 20 mg in 0.4 mL pre-filled syringe | Injection |
| Trexject | LM | MP | C7488 C7518 |
| 4 | 5 | 1 |
|
| |
Injection 20 mg in 0.8 mL pre-filled syringe | Injection |
| Methoblastin PFS | PF | MP | C7488 C7518 |
| 4 | 5 | 4 |
|
| |
Injection 25 mg in 0.5 mL pre-filled syringe | Injection |
| Trexject | LM | MP | C7488 C7518 |
| 4 | 5 | 1 |
|
| |
Injection 25 mg in 1 mL pre-filled syringe | Injection |
| Methoblastin PFS | PF | MP | C7488 C7518 |
| 4 | 5 | 4 |
|
| |
Injection 50 mg in 2 mL vial | Injection | a | Methotrexate Accord | OD | MP |
|
| 5 | 5 | 1 |
|
| |
a | Hospira Pty Limited | PF | MP |
|
| 5 | 5 | 5 |
|
| |||
| Methotrexate Accord | OD | MP |
|
| See Note 2 | See Note 2 | 1 |
| C(100) | |||
MP |
| P6276 | See Note 2 | See Note 2 | 1 |
| C(100) | ||||||
| Hospira Pty Limited | PF | MP |
|
| See Note 2 | See Note 2 | 5 |
| C(100) | |||
MP |
| P6276 | See Note 2 | See Note 2 | 5 |
| C(100) | ||||||
Solution concentrate for I.V. infusion 500 mg in 20 mL vial | Injection |
| Hospira Pty Limited | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
Solution concentrate for I.V. infusion 1000 mg in 10 mL vial | Injection |
| Hospira Pty Limited | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
| Methaccord | EA | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
| Methotrexate Accord | OD | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
| Pfizer Australia Pty Ltd | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |||
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
Solution concentrate for I.V. infusion 5000 mg in 50 mL vial | Injection |
| Methotrexate Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| PB(100) | |
MP |
| P6276 | See Note 3 | See Note 3 | 1 |
| PB(100) | ||||||
Tablet 2.5 mg | Oral |
| Methoblastin | PF | MP |
|
| 30 | 5 | 30 |
|
| |
Tablet 10 mg | Oral |
| Methoblastin | PF | MP |
|
| 15 | 3 | 15 |
|
| |
MP |
| P5648 | 50 | 2 | 50 |
|
| ||||||
Methoxyflurane | Liquid for inhalation 999 mg per g, 3 mL (with inhaler) | Inhalation by mouth |
| Penthrox | DV | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 1 | 1 | D(MP) |
Methoxy polyethylene glycol-epoetin beta | Injection 30 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) |
Injection 50 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Injection 75 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Injection 100 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Injection 120 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Injection 200 micrograms in 0.3 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Injection 360 micrograms in 0.6 mL pre-filled syringe | Injection |
| Mircera | RO | MP | C6260 C6294 |
| 2 | 5 | 1 |
| D(100) | |
Methyldopa | Tablet 250 mg (as sesquihydrate) | Oral | a | Aldomet | AS | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Hydopa | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Methylnaltrexone | Solution for injection containing methylnaltrexone bromide 12 mg in 0.6 mL | Injection |
| Relistor | LM | MP NP | C6180 |
| 7 | 0 | 1 |
|
|
MP NP | C6180 |
| 7 | 0 | 7 |
|
| ||||||
Methylphenidate | Capsule containing methylphenidate hydrochloride 10 mg (modified release) | Oral |
| Ritalin LA | NV | MP NP | C6298 |
| 30 | 5 | 30 |
|
|
Capsule containing methylphenidate hydrochloride 20 mg (modified release) | Oral |
| Ritalin LA | NV | MP NP | C6298 |
| 30 | 5 | 30 |
|
| |
Capsule containing methylphenidate hydrochloride 30 mg (modified release) | Oral |
| Ritalin LA | NV | MP NP | C6298 |
| 30 | 5 | 30 |
|
| |
Capsule containing methylphenidate hydrochloride 40 mg (modified release) | Oral |
| Ritalin LA | NV | MP NP | C6298 |
| 30 | 5 | 30 |
|
| |
Tablet containing methylphenidate hydrochloride 10 mg | Oral | a | Artige | NM | MP NP | C6226 |
| 100 | 5 | 100 |
|
| |
a | Ritalin 10 | NV | MP NP | C6226 |
| 100 | 5 | 100 |
|
| |||
Tablet containing methylphenidate hydrochloride 18 mg (extended release) | Oral |
| Concerta | JC | MP NP | C6249 |
| 30 | 5 | 30 |
|
| |
Tablet containing methylphenidate hydrochloride 27 mg (extended release) | Oral |
| Concerta | JC | MP NP | C6249 |
| 30 | 5 | 30 |
|
| |
Tablet containing methylphenidate hydrochloride 36 mg (extended release) | Oral |
| Concerta | JC | MP NP | C6249 |
| 30 | 5 | 30 |
|
| |
Tablet containing methylphenidate hydrochloride 54 mg (extended release) | Oral |
| Concerta | JC | MP NP | C6249 |
| 30 | 5 | 30 |
|
| |
Methylprednisolone | Cream containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Advantan | BN | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
|
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| ||||||
Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | a | Depo-Medrol | PF | MP NP | C6273 |
| 5 | 0 | 5 |
|
| |
PDP | C6209 |
| 5 | 0 | 5 |
|
| ||||||
a | Depo-Nisolone | FZ | MP NP | C6273 |
| 5 | 0 | 5 |
|
| |||
PDP | C6209 |
| 5 | 0 | 5 |
|
| ||||||
Lotion containing methylprednisolone aceponate 1 mg per g, 20 g | Application |
| Advantan | BN | MP NP | C6218 C6231 C6232 C6246 C6263 C6302 | P6302 | 1 | 0 | 1 |
|
| |
MP NP | C6218 C6231 C6232 C6246 C6263 C6302 | P6232 | 2 | 5 | 1 |
|
| ||||||
MP NP | C6218 C6231 C6232 C6246 C6263 C6302 | P6246 | 3 | 5 | 1 |
|
| ||||||
MP NP | C6218 C6231 C6232 C6246 C6263 C6302 | P6218 P6263 | 4 | 5 | 1 |
|
| ||||||
MP NP | C6218 C6231 C6232 C6246 C6263 C6302 | P6231 | 5 | 5 | 1 |
|
| ||||||
Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Advantan | BN | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| ||||||
Ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Advantan | BN | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| ||||||
MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| ||||||
Powder for injection 40 mg (as sodium succinate) | Injection |
| Methylpred | AL | MP NP |
|
| 5 | 0 | 5 |
|
| |
Powder for injection 40 mg (as sodium succinate) with diluent | Injection |
| Solu-Medrol | PF | MP NP |
|
| 5 | 0 | 1 |
|
| |
Powder for injection 1 g (as sodium succinate) | Injection | a | Methylpred | AL | MP NP |
|
| 1 | 0 | 1 |
|
| |
a | Methylprednisolone Alphapharm | AF | MP NP |
|
| 1 | 0 | 1 |
|
| |||
a | Solu-Medrol | PF | MP NP |
|
| 1 | 0 | 1 |
|
| |||
Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | Injection |
| Maxolon | IL | MP NP MW PDP |
|
| 10 | 0 | 10 |
|
|
MP NP |
| P6084 | 40 | 0 | 10 |
|
| ||||||
Tablet containing 10 mg metoclopramide hydrochloride (as monohydrate) | Oral | a | APO-Metoclopramide | TX | MP NP MW PDP |
|
| 25 | 0 | 25 |
|
| |
a | EMEXLON | RW | MP NP MW PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Maxolon | IL | MP NP MW PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Metoclopramide AN | EA | MP NP MW PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Pramin | AF | MP NP MW PDP |
|
| 25 | 0 | 25 |
|
| |||
Metoprolol | Tablet containing metoprolol tartrate 50 mg | Oral | b | APO-Metoprolol | TX | MP NP |
|
| 100 | 5 | 100 |
|
|
b | Betaloc | AP | MP NP |
|
| 100 | 5 | 100 |
|
| |||
b | Chem mart Metoprolol | CH | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Lopresor 50 | NV | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Metoprolol AN | EA | MP NP |
|
| 100 | 5 | 100 |
|
| |||
b | Metoprolol Sandoz | SZ | MP NP |
|
| 100 | 5 | 100 |
|
| |||
b | Metrol 50 | RW | MP NP |
|
| 100 | 5 | 100 |
|
| |||
b | Minax 50 | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Mistrom | ER | MP NP |
|
| 100 | 5 | 100 |
|
| |||
b | Terry White Chemists Metoprolol | TW | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet containing metoprolol tartrate 100 mg | Oral | b | APO-Metoprolol | TX | MP NP |
|
| 60 | 5 | 60 |
|
| |
b | Betaloc | AP | MP NP |
|
| 60 | 5 | 60 |
|
| |||
b | Chem mart Metoprolol | CH | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Lopresor 100 | NV | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Metoprolol AN | EA | MP NP |
|
| 60 | 5 | 60 |
|
| |||
b | Metoprolol Sandoz | SZ | MP NP |
|
| 60 | 5 | 60 |
|
| |||
b | Metrol 100 | RW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
b | Minax 100 | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Mistrom | ER | MP NP |
|
| 60 | 5 | 60 |
|
| |||
b | Terry White Chemists Metoprolol | TW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Metoprolol succinate | Tablet 23.75 mg (controlled release) | Oral | a | Metrol-XL 23.75 | RW | MP NP | C5324 |
| 15 | 0 | 15 |
|
|
a | Minax XL | AF | MP NP | C5324 |
| 15 | 0 | 15 |
|
| |||
Tablet 47.5 mg (controlled release) | Oral | a | Metrol-XL 47.5 | RW | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |
a | Minax XL | AF | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
a | Toprol-XL 47.5 | AP | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
Tablet 95 mg (controlled release) | Oral | a | Metrol-XL 95 | RW | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |
a | Minax XL | AF | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
a | Toprol-XL 95 | AP | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
Tablet 190 mg (controlled release) | Oral | a | Metrol-XL 190 | RW | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |
a | Minax XL | AF | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
a | Toprol-XL 190 | AP | MP NP | C5324 |
| 30 | 5 | 30 |
|
| |||
Metronidazole | Suppositories 500 mg, 10 | Rectal |
| Flagyl | SW | MP NP PDP |
|
| 1 | 0 | 1 |
|
|
Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral |
| Flagyl S | SW | MP NP PDP |
|
| 1 | 0 | 1 |
|
| |
Tablet 200 mg | Oral | a | Flagyl | SW | PDP |
|
| 21 | 0 | 21 |
|
| |
a | Metrogyl 200 | AF | PDP |
|
| 21 | 0 | 21 |
|
| |||
a | Metronide 200 | AV | PDP |
|
| 21 | 0 | 21 |
|
| |||
a | Flagyl | SW | MP NP |
|
| 21 | 1 | 21 |
|
| |||
a | Metrogyl 200 | AF | MP NP |
|
| 21 | 1 | 21 |
|
| |||
a | Metronide 200 | AV | MP NP |
|
| 21 | 1 | 21 |
|
| |||
Tablet 400 mg | Oral | a | Flagyl | SW | PDP | C5701 |
| 21 | 0 | 21 |
|
| |
a | Metrogyl 400 | AF | PDP | C5701 |
| 21 | 0 | 21 |
|
| |||
a | Metronide 400 | AV | PDP | C5701 |
| 21 | 0 | 21 |
|
| |||
a | Flagyl | SW | MP NP | C5702 |
| 21 | 1 | 21 |
|
| |||
a | Metrogyl 400 | AF | MP NP | C5702 |
| 21 | 1 | 21 |
|
| |||
a | Metronide 400 | AV | MP NP | C5702 |
| 21 | 1 | 21 |
|
| |||
Mianserin | Tablet containing mianserin hydrochloride 10 mg | Oral |
| Lumin 10 | AF | MP NP | C6278 |
| 50 | 5 | 50 |
|
|
Tablet containing mianserin hydrochloride 20 mg | Oral |
| Lumin 20 | AF | MP NP | C6278 |
| 50 | 5 | 50 |
|
| |
Miconazole | Cream containing miconazole nitrate 20 mg per g, 30 g | Application |
| Daktarin | JT | MP NP | C6434 |
| 1 | 2 | 1 |
|
|
Cream containing miconazole nitrate 20 mg per g, 70 g | Application |
| Daktarin | JT | MP NP | C6434 |
| 1 | 1 | 1 |
|
| |
Powder containing miconazole nitrate 20 mg per g, 30 g | Application |
| Daktarin | JT | MP NP | C6434 |
| 1 | 2 | 1 |
|
| |
Tincture 20 mg per mL, 30 mL | Application |
| Daktarin Tincture | JT | MP NP | C6434 |
| 1 | 2 | 1 |
|
| |
Midazolam | Injection 5 mg (as hydrochloride) in 1 mL | Injection |
| Pfizer Australia Pty Ltd | PF | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 10 | 10 | D(MP) |
Midostaurin | Capsule 25 mg | Oral |
| Rydapt | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 56 |
| D(100) |
|
|
|
|
|
| MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 112 |
| D(100) |
Mifepristone and misoprostol | Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms | Oral |
| MS-2 Step | XH | MP | C4790 |
| 1 | 0 | 1 |
|
|
Milk powder lactose intolerance formula | Oral powder 900 g (S-26 Original Alula L.I.) | Oral |
| S-26 Original Alula L.I. | AS | MP NP | C7257 |
| 5 | 0 | 1 |
|
|
Milk powder -- synthetic | Low calcium oral powder 400 g (Locasol) | Oral |
| Locasol | SB | MP NP | C6208 |
| 8 | 5 | 1 |
|
|
Milk protein and fat formula with vitamins and minerals -- carbohydrate free | Oral powder 225 g (Carbohydrate Free Mixture) | Oral |
| Carbohydrate Free Mixture | SB | MP NP | C6658 |
| 24 | 5 | 1 |
|
|
Minocycline | Tablet 50 mg (as hydrochloride) | Oral | a | Akamin 50 | AF | MP NP | C5995 |
| 60 | 5 | 60 |
|
|
a | Minomycin-50 | QA | MP NP | C5995 |
| 60 | 5 | 60 |
|
| |||
Minoxidil | Tablet 10 mg | Oral |
| Loniten | PF | MP NP | C5177 |
| 100 | 5 | 100 |
|
|
Mirtazapine | Tablet 15 mg | Oral | a | APO-Mirtazapine | TX | MP NP | C5650 |
| 30 | 5 | 30 |
|
|
a | Axit 15 | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | MIRTANZA | RF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Tablet 15 mg (orally disintegrating) | Oral | a | Avanza SolTab | MK | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |
a | Milivin OD 15 | DO | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN ODT | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine Sandoz ODT 15 | SZ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Remeron SolTab | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Tablet 30 mg | Oral | a | APO-Mirtazapine | TX | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |
a | Avanza | MK | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Axit 30 | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Mirtazapine | CH | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | MIRTANZA | RF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine GH | GQ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine Sandoz | SZ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazon | RW | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Mirtazapine | TW | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Tablet 30 mg (orally disintegrating) | Oral | a | Avanza SolTab | MK | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |
a | Milivin OD 30 | DO | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN ODT | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine Sandoz ODT 30 | SZ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Remeron SolTab | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Tablet 45 mg | Oral | a | APO-Mirtazapine | TX | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |
a | Axit 45 | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Mirtazapine | CH | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | MIRTANZA | RF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine GH | GQ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine Sandoz | SZ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazon | RW | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Mirtazapine | TW | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Tablet 45 mg (orally disintegrating) | Oral | a | Avanza SolTab | MK | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |
a | Milivin OD 45 | DO | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine AN ODT | EA | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Mirtazapine Sandoz ODT 45 | SZ | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
a | Remeron SolTab | AF | MP NP | C5650 |
| 30 | 5 | 30 |
|
| |||
Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection |
| Mitozantrone Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
| Onkotrone | BX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Injection 25 mg (as hydrochloride) in 12.5 mL | Injection |
| Onkotrone | BX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Moclobemide | Tablet 150 mg | Oral | a | Amira 150 | AF | MP NP | C5650 |
| 60 | 5 | 60 |
|
|
a | APO-Moclobemide | TX | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Aurorix | GO | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Clobemix | ED | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Moclobemide AN | EA | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Moclobemide Sandoz | SZ | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Mohexal | HX | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
Tablet 300 mg | Oral | a | Amira 300 | AF | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |
a | APO-Moclobemide | TX | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Aurorix 300 mg | GO | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Clobemix | ED | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | GenRx Moclobemide | GX | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Moclobemide AN | EA | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
a | Moclobemide Sandoz | SZ | MP NP | C5650 |
| 60 | 5 | 60 |
|
| |||
Modafinil | Tablet 100 mg | Oral | a | APO-Modafinil | TX | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
|
a | Modafin | RW | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
a | Modafinil AN | EA | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
a | Modafinil GH | GQ | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
a | Modafinil Mylan | AF | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
a | Modafinil Sandoz | SZ | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
a | Modavigil | TB | MP | C6547 C8694 |
| 120 | 5 | 60 |
|
| |||
Mometasone | Cream containing mometasone furoate 1 mg per g, 15 g | Application | a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
|
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Elocon Alcohol Free | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
Lotion containing mometasone furoate 1 mg per g, 30 mL | Application | a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 3 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 3 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 3 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 3 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 P6263 | 4 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 P6263 | 4 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 P6263 | 4 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 P6263 | 4 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 5 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 5 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 5 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 5 | 5 | 1 |
|
| |||
Ointment containing mometasone furoate 1 mg per g, 15 g | Application | a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P4957 | 1 | 0 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6232 | 2 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6246 | 4 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6218 | 6 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6263 | 8 | 5 | 1 |
|
| |||
a | Elocon | MK | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
a | Momasone | QA | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
a | Novasone | AF | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
a | Zatamil | EO | MP NP | C4957 C6218 C6231 C6232 C6246 C6263 | P6231 | 10 | 5 | 1 |
|
| |||
Montelukast | Tablet, chewable, 4 mg (as sodium) | Oral | a | APO-Montelukast | TX | MP NP | C6666 |
| 28 | 5 | 28 |
|
|
a | Auro-Montelukast Tabs 4 | DO | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Lukair | AL | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast AN | EA | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast APOTEX | GX | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast GH | GQ | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast Sandoz 4 | SZ | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Respikast 4 | RW | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
a | Singulair | MK | MP NP | C6666 |
| 28 | 5 | 28 |
|
| |||
Tablet, chewable, 5 mg (as sodium) | Oral | a | APO-Montelukast | TX | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |
a | Auro-Montelukast Tabs 5 | DO | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Lukair | AL | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast AN | EA | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast APOTEX | GX | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast GH | GQ | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Montelukast Sandoz 5 | SZ | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Respikast 5 | RW | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
a | Singulair | MK | MP NP | C6674 C7781 |
| 28 | 5 | 28 |
|
| |||
Morphine | Capsule containing morphine sulfate pentahydrate 10 mg (containing sustained release pellets) | Oral |
| Kapanol | YN | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Capsule containing morphine sulfate pentahydrate 20 mg (containing sustained release pellets) | Oral |
| Kapanol | YN | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Capsule containing morphine sulfate pentahydrate 30 mg (controlled release) | Oral |
| MS Mono | MF | MP NP | C4556 |
| 14 | 0 | 14 |
|
|
| Capsule containing morphine sulfate pentahydrate 50 mg (containing sustained release pellets) | Oral |
| Kapanol | YN | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Capsule containing morphine sulfate pentahydrate 60 mg (controlled release) | Oral |
| MS Mono | MF | MP NP | C4556 |
| 14 | 0 | 14 |
|
|
| Capsule containing morphine sulfate pentahydrate 90 mg (controlled release) | Oral |
| MS Mono | MF | MP NP | C4556 |
| 14 | 0 | 14 |
|
|
| Capsule containing morphine sulfate pentahydrate 100 mg (containing sustained release pellets) | Oral |
| Kapanol | YN | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Capsule containing morphine sulfate pentahydrate 120 mg (controlled release) | Oral |
| MS Mono | MF | MP NP | C4556 |
| 14 | 0 | 14 |
|
|
| Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL | Injection | a | Morphine Juno | JU | PDP MP NP MW |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine sulfate pentahydrate 10 mg in 1 mL | Injection | a | Hospira Pty Limited | PF | PDP MP NP MW |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | Injection |
| Hospira Pty Limited | PF | PDP MP NP MW |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL | Injection |
| Morphine Juno | JU | PDP MP NP |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | Injection |
| Hospira Pty Limited | PF | PDP MP NP |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine hydrochloride trihydrate 50 mg in 5 mL | Injection |
| Morphine Juno | JU | MP NP |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine hydrochloride trihydrate 100 mg in 5 mL | Injection |
| Morphine Juno | JU | MP NP |
|
| 5 | 0 | 5 |
|
|
| Injection containing morphine tartrate 120 mg in 1.5 mL | Injection |
| Hospira Pty Limited | PF | MP NP |
|
| 5 | 0 | 5 |
|
|
| Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 200 mL | Oral |
| Ordine 2 | MF | MP NP | C4959 |
| 1 | 0 | 1 |
|
|
|
|
|
|
|
| PDP | C4926 |
| 1 | 0 | 1 |
|
|
| Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 200 mL | Oral |
| Ordine 5 | MF | MP NP | C4959 |
| 1 | 0 | 1 |
|
|
|
|
|
|
|
| PDP | C4926 |
| 1 | 0 | 1 |
|
|
| Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 200 mL | Oral |
| Ordine 10 | MF | MP NP | C4959 |
| 1 | 0 | 1 |
|
|
|
|
|
|
|
| PDP | C4926 |
| 1 | 0 | 1 |
|
|
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 20 mg per sachet | Oral |
| MS Contin Suspension 20 mg | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 30 mg per sachet | Oral |
| MS Contin Suspension 30 mg | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 60 mg per sachet | Oral |
| MS Contin Suspension 60 mg | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 100 mg per sachet | Oral |
| MS Contin Suspension 100 mg | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 200 mg per sachet | Oral |
| MS Contin Suspension 200 mg | MF | MP NP | C4900 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 5 mg (controlled release) | Oral |
| MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 10 mg | Oral |
| Sevredol | MF | MP NP | C4960 C6168 | P4960 | 20 | 0 | 20 |
|
|
|
|
|
|
|
| MP NP | C4960 C6168 | P6168 | 20 | 2 | 20 |
|
|
| Tablet containing morphine sulfate pentahydrate 10 mg (controlled release) | Oral | a | Momex SR 10 | RW | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR AN | EA | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MORPHINE MR APOTEX | TX | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR Mylan | AF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 15 mg (controlled release) | Oral |
| MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 20 mg | Oral |
| Sevredol | MF | MP NP | C4960 C6168 | P4960 | 20 | 0 | 20 |
|
|
|
|
|
|
|
| MP NP | C4960 C6168 | P6168 | 20 | 2 | 20 |
|
|
| Tablet containing morphine sulfate pentahydrate 30 mg | Oral |
| Anamorph | RW | MP NP | C4959 |
| 20 | 0 | 20 |
|
|
|
|
|
|
|
| PDP | C4926 |
| 20 | 0 | 20 |
|
|
| Tablet containing morphine sulfate pentahydrate 30 mg (controlled release) | Oral | a | Momex SR 30 | RW | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR AN | EA | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MORPHINE MR APOTEX | TX | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR Mylan | AF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 60 mg (controlled release) | Oral | a | Momex SR 60 | RW | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR AN | EA | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MORPHINE MR APOTEX | TX | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR Mylan | AF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 100 mg (controlled release) | Oral | a | Momex SR 100 | RW | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR AN | EA | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MORPHINE MR APOTEX | TX | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | Morphine MR Mylan | AF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
|
|
| a | MS Contin | MF | MP NP | C4556 |
| 28 | 0 | 28 |
|
|
| Tablet containing morphine sulfate pentahydrate 200 mg (controlled release) | Oral |
| MS Contin | MF | MP NP | C4900 C6151 | P4900 | 28 | 0 | 28 |
|
|
|
|
|
|
|
| MP NP | C4900 C6151 | P6151 | 28 | 2 | 28 |
|
|
Moxonidine | Tablet 200 micrograms | Oral | a | APO-Moxonidine | TX | MP NP | C4944 |
| 30 | 5 | 30 |
|
|
a | Moxonidine GH | GQ | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Moxonidine GX | SZ | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Moxonidine MYL | AF | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Physiotens | GO | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
Tablet 400 micrograms | Oral | a | APO-Moxonidine | TX | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |
a | Moxonidine GH | GQ | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Moxonidine GX | SZ | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Moxonidine MYL | AF | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
a | Physiotens | GO | MP NP | C4944 |
| 30 | 5 | 30 |
|
| |||
Mupirocin | Nasal ointment 20 mg (as calcium) per g, 3 g | Nasal |
| Bactroban | GK | MP NP | C6647 |
| 1 | 0 | 1 |
|
|
Mycobacterium bovis (Bacillus Calmette and Guerin), Tice strain | Vial containing powder for intravesical administration approximately 5 x 108 CFU | Intravesical |
| OncoTICE | MK | MP | C5540 |
| 3 | 1 | 3 |
|
|
MP | C5597 |
| 3 | 1 | 3 |
| C(100) | ||||||
Mycophenolic acid | Capsule containing mycophenolate mofetil 250 mg | Oral | a | Ceptolate | AF | MP |
|
| 300 | 5 | 50 |
|
|
a | APO-Mycophenolate | TX | MP |
|
| 300 | 5 | 100 |
|
| |||
a | CellCept | RO | MP |
|
| 300 | 5 | 100 |
|
| |||
a | Mycophenolate Sandoz | SZ | MP |
|
| 300 | 5 | 100 |
|
| |||
a | Pharmacor Mycophenolate 250 | CR | MP |
|
| 300 | 5 | 100 |
|
| |||
a | Ceptolate | AF | MP |
| P5600 P5601 P5626 P5653 | 600 | 5 | 50 |
| C(100) | |||
a | APO-Mycophenolate | TX | MP |
| P5600 P5601 P5626 P5653 | 600 | 5 | 100 |
| C(100) | |||
a | CellCept | RO | MP |
| P5600 P5601 P5626 P5653 | 600 | 5 | 100 |
| C(100) | |||
a | Mycophenolate Sandoz | SZ | MP |
| P5600 P5601 P5626 P5653 | 600 | 5 | 100 |
| C(100) | |||
a | Pharmacor Mycophenolate 250 | CR | MP |
| P5600 P5601 P5626 P5653 | 600 | 5 | 100 |
| C(100) | |||
Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL | Oral |
| CellCept | RO | MP |
|
| 1 | 5 | 1 |
|
| |
MP |
| P5554 P5555 P5794 P5795 | 2 | 5 | 1 |
| C(100) | ||||||
Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral |
| Myfortic | NV | MP |
|
| 120 | 5 | 120 |
|
| |
MP |
| P4084 P4095 P4108 P4146 | 240 | 5 | 120 |
| C(100) | ||||||
Tablet (enteric coated) containing mycophenolate sodium equivalent to 360 mg mycophenolic acid | Oral |
| Myfortic | NV | MP |
|
| 120 | 5 | 120 |
|
| |
MP |
| P4084 P4095 P4108 P4146 | 240 | 5 | 120 |
| C(100) | ||||||
Tablet containing mycophenolate mofetil 500 mg | Oral | a | APO-Mycophenolate | TX | MP |
|
| 150 | 5 | 50 |
|
| |
a | CellCept | RO | MP |
|
| 150 | 5 | 50 |
|
| |||
a | Ceptolate | AF | MP |
|
| 150 | 5 | 50 |
|
| |||
a | MycoCept | RF | MP |
|
| 150 | 5 | 50 |
|
| |||
a | Mycophenolate AN | EA | MP |
|
| 150 | 5 | 50 |
|
| |||
a | Mycophenolate Sandoz | SZ | MP |
|
| 150 | 5 | 50 |
|
| |||
a | Pharmacor Mycophenolate 500 | CR | MP |
|
| 150 | 5 | 50 |
|
| |||
a | APO-Mycophenolate | TX | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | CellCept | RO | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | Ceptolate | AF | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | MycoCept | RF | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | Mycophenolate AN | EA | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | Mycophenolate Sandoz | SZ | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
a | Pharmacor Mycophenolate 500 | CR | MP |
| P5554 P5555 P5794 P5795 | 300 | 5 | 50 |
| C(100) | |||
Nadroparin | Injection containing nadroparin calcium (1,900 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 20 | 0 | 2 |
|
|
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (2,850 I.U. anti-Xa) in 0.3 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 20 | 0 | 2 |
|
| |
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (3,800 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 20 | 0 | 2 |
|
| |
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (5,700 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 20 | 0 | 2 |
|
| |
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (7,600 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 10 | 1 | 2 |
|
| |
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (9,500 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection |
| Fraxiparine | AS | MP NP |
|
| 10 | 1 | 2 |
|
| |
MP NP |
| P6014 | 20 | 3 | 2 |
|
| ||||||
Injection containing nadroparin calcium (11,400 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection |
| Fraxiparine Forte | AS | MP NP |
|
| 10 | 1 | 2 |
|
| |
Injection containing nadroparin calcium (15,200 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection |
| Fraxiparine Forte | AS | MP NP |
|
| 10 | 1 | 2 |
|
| |
Injection containing nadroparin calcium (19,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection |
| Fraxiparine Forte | AS | MP NP |
|
| 10 | 1 | 2 |
|
| |
Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | Nasal |
| Synarel | PF | MP | C6517 C6552 |
| 1 | 5 | 1 |
|
|
MP | C5046 |
| 2 | 0 | 1 |
| C(100) | ||||||
Naloxone | Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule | Injection | a | Naloxone Hydrochloride (DBL) | PF | MP NP PDP |
|
| 5 | 0 | 5 |
|
|
a | Naloxone Juno | JU | MP NP PDP |
|
| 5 | 0 | 5 |
|
| |||
a | NARCAN | FF | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 10 | 10 | C(MP) | |||
Injection containing naloxone hydrochloride 2 mg in 2 mL pre-filled syringe | Injection |
| Prenoxad | FF | PDP MP NP |
|
| 1 | 0 | 1 |
|
| |
Naltrexone | Tablet containing naltrexone hydrochloride 50 mg | Oral | a | APO-Naltrexone | TX | MP NP | C5364 |
| 30 | 1 | 30 |
|
|
a | Naltrexone GH | GQ | MP NP | C5364 |
| 30 | 1 | 30 |
|
| |||
Naproxen | Oral suspension 125 mg per 5 mL, 474 mL | Oral |
| Phebra Naproxen Suspension | FF | MP NP | C4124 C4159 C6150 |
| 1 | 3 | 1 |
|
|
Tablet 250 mg | Oral | a | Inza 250 | AF | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |
a | Naprosyn | IX | PDP | C6256 C6282 |
| 100 | 0 | 50 |
|
| |||
a | Inza 250 | AF | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
a | Naprosyn | IX | MP NP | C6149 C6214 C6283 |
| 100 | 3 | 50 |
|
| |||
Tablet 500 mg | Oral | a | Inza 500 | AF | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |
a | Naprosyn | IX | PDP | C6256 C6282 |
| 50 | 0 | 50 |
|
| |||
a | Inza 500 | AF | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
a | Naprosyn | IX | MP NP | C6149 C6214 C6283 |
| 50 | 3 | 50 |
|
| |||
Tablet containing naproxen sodium 550 mg | Oral | a | Anaprox 550 | IX | PDP | C6368 C6387 |
| 50 | 0 | 50 |
|
| |
a | Crysanal | IY | PDP | C6368 C6387 |
| 50 | 0 | 50 |
|
| |||
a | Anaprox 550 | IX | MP NP | C6196 C6463 C6471 |
| 50 | 3 | 50 |
|
| |||
a | Crysanal | IY | MP NP | C6196 C6463 C6471 |
| 50 | 3 | 50 |
|
| |||
Tablet 750 mg (sustained release) | Oral | a | Naprosyn SR750 | IX | PDP | C6256 C6282 |
| 28 | 0 | 28 |
|
| |
a | Proxen SR 750 | IY | PDP | C6256 C6282 |
| 28 | 0 | 28 |
|
| |||
a | Naprosyn SR750 | IX | MP NP | C6149 C6214 C6283 |
| 28 | 3 | 28 |
|
| |||
a | Proxen SR 750 | IY | MP NP | C6149 C6214 C6283 |
| 28 | 3 | 28 |
|
| |||
Tablet 1 g (sustained release) | Oral | a | Naprosyn SR1000 | IX | PDP | C6256 C6282 |
| 28 | 0 | 28 |
|
| |
a | Proxen SR 1000 | IY | PDP | C6256 C6282 |
| 28 | 0 | 28 |
|
| |||
a | Naprosyn SR1000 | IX | MP NP | C6149 C6214 C6283 |
| 28 | 3 | 28 |
|
| |||
a | Proxen SR 1000 | IY | MP NP | C6149 C6214 C6283 |
| 28 | 3 | 28 |
|
| |||
Naratriptan | Tablet 2.5 mg (as hydrochloride) | Oral |
| Naramig | AS | MP NP | C4562 C5849 C5850 C5859 C5860 C5887 |
| 4 | 5 | 2 |
|
|
Natalizumab | Solution concentrate for I.V. infusion 300 mg in 15 mL | Injection |
| Tysabri | BD | MP | C6845 C7697 C7769 |
| 1 | 5 | 1 |
| D(100) |
Nebivolol | Tablet 1.25 mg (as hydrochloride) | Oral | a | APO-Nebivolol | TX | MP NP | C5324 |
| 56 | 5 | 28 |
|
|
|
| a | Nebilet | FK | MP NP | C5324 |
| 56 | 5 | 28 |
|
| |
Tablet 5 mg (as hydrochloride) | Oral | a | APO-Nebivolol | TX | MP NP | C5324 |
| 28 | 5 | 28 |
|
| |
|
| a | Nebilet | FK | MP NP | C5324 |
| 28 | 5 | 28 |
|
| |
Tablet 10 mg (as hydrochloride) | Oral | a | APO-Nebivolol | TX | MP NP | C5324 |
| 28 | 5 | 28 |
|
| |
|
|
| a | Nebilet | FK | MP NP | C5324 |
| 28 | 5 | 28 |
|
|
Nedocromil | Pressurised inhalation containing nedocromil sodium 2 mg per dose, 112 doses (CFC-free formulation) | Inhalation by mouth |
| Tilade CFC-Free | SW | MP NP |
|
| 1 | 5 | 1 |
|
|
Netupitant with Palonosetron | Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride) | Oral |
| Akynzeo | MF | MP NP | C5991 C5994 C6879 C6937 |
| 1 | 5 | 1 |
|
|
Nevirapine | Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL | Oral |
| Viramune | BY | MP | C4454 C4512 |
| 10 | 5 | 1 |
| D(100) |
Tablet 200 mg | Oral | a | Nevirapine Alphapharm | AF | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |
a | Viramune | BY | MP | C4454 C4512 |
| 120 | 5 | 60 |
| D(100) | |||
Tablet 400 mg (extended release) | Oral | a | Nevirapine XR APOTEX | TX | MP | C4454 C4526 |
| 60 | 5 | 30 |
| D(100) | |
a | Viramune XR | BY | MP | C4454 C4526 |
| 60 | 5 | 30 |
| D(100) | |||
Nicorandil | Tablets 10 mg, 60 | Oral | a | Ikorel | SW | MP NP |
|
| 1 | 5 | 1 |
|
|
a | Ikotab | QA | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Tablets 20 mg, 60 | Oral | a | Ikorel | SW | MP NP |
|
| 1 | 5 | 1 |
|
| |
a | Ikotab | QA | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Nicotine | Gum 2 mg | Buccal |
| Nicotinell | ON | MP NP | C5140 C6848 |
| 432 | 1 | 216 |
|
|
Gum 4 mg | Buccal |
| Nicotinell | ON | MP NP | C5140 C6848 |
| 216 | 2 | 216 |
|
| |
Lozenge 2 mg | Buccal |
| Nicotinell | ON | MP NP | C5140 C6848 |
| 216 | 2 | 216 |
|
| |
Lozenge 4 mg | Buccal |
| Nicotinell | ON | MP NP | C5140 C6848 |
| 216 | 2 | 216 |
|
| |
Transdermal patch 17.5 mg | Transdermal |
| Nicotinell Step 3 | ON | MP NP | C6848 |
| 28 | 2 | 28 |
|
| |
Transdermal patch 35 mg | Transdermal |
| Nicotinell Step 2 | ON | MP NP | C6848 |
| 28 | 2 | 28 |
|
| |
Transdermal patch 39.4 mg | Transdermal |
| nicorette 16hr Invisipatch | JT | MP NP | C5140 C6848 |
| 28 | 2 | 28 |
|
| |
Transdermal patch 52.5 mg | Transdermal |
| Nicotinell Step 1 | ON | MP NP | C5140 C6848 |
| 28 | 2 | 28 |
|
| |
Transdermal patch 114 mg | Transdermal |
| Nicabate P | GC | MP NP | C5140 C6848 |
| 28 | 2 | 28 |
|
| |
Nifedipine | Tablet 10 mg | Oral |
| Adefin 10 | AF | MP NP |
|
| 60 | 5 | 60 |
|
|
Tablet 20 mg | Oral |
| Adefin 20 | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |
Tablet 20 mg (controlled release) | Oral |
| Adalat Oros 20mg | BN | MP NP |
|
| 30 | 5 | 30 |
|
| |
Tablet 30 mg (controlled release) | Oral | a | Adalat Oros 30 | BN | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Addos XR 30 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Adefin XL 30 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Nifedipine XR | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet 60 mg (controlled release) | Oral | a | Adalat Oros 60 | BN | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Addos XR 60 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Adefin XL 60 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Nifedipine XR | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Nilotinib | Capsule 150 mg (as hydrochloride monohydrate) | Oral |
| Tasigna | NV | MP | C6958 C6966 C6967 |
| 120 | 5 | 120 |
|
|
Capsule 200 mg (as hydrochloride monohydrate) | Oral |
| Tasigna | NV | MP | C6954 C6977 |
| 120 | 5 | 120 |
|
| |
Nilutamide | Tablet 150 mg | Oral |
| Anandron | SW | MP NP | C5647 C5785 |
| 30 | 5 | 30 |
|
|
Nintedanib | Capsule 100 mg | Oral |
| Ofev | BY | MP | C6950 C6961 C6975 |
| 60 | 5 | 60 |
|
|
Capsule 150 mg | Oral |
| Ofev | BY | MP | C6950 C6961 C6975 |
| 60 | 5 | 60 |
|
| |
Nitrazepam | Tablet 5 mg | Oral | a | Alodorm | AF | MP NP PDP |
|
| 25 | 0 | 25 |
|
|
a | Mogadon | IL | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Alodorm | AF | MP NP |
| P6175 | 50 | 3 | 25 |
|
| |||
a | Mogadon | IL | MP NP |
| P6175 | 50 | 3 | 25 |
|
| |||
a | Alodorm | AF | MP NP |
| P5661 P5771 P5941 P5950 | 50 | 5 | 25 |
|
| |||
a | Mogadon | IL | MP NP |
| P5661 P5771 P5941 P5950 | 50 | 5 | 25 |
|
| |||
Nitrofurantoin | Capsule 50 mg | Oral |
| Macrodantin | PF | MP NP MW |
|
| 30 | 1 | 30 |
|
|
Capsule 100 mg | Oral |
| Macrodantin | PF | MP NP MW |
|
| 30 | 1 | 30 |
|
| |
Nivolumab | Injection concentrate for I.V. infusion 40 mg in 4 mL | Injection |
| Opdivo | BQ | MP | C6070 C6095 C6111 C6997 C6999 C7567 C7787 C7802 C7864 C8141 C8143 C8146 C8182 C8220 C8552 C8568 C8571 C8573 C8581 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Injection concentrate for I.V. infusion 100 mg in 10 mL | Injection |
| Opdivo | BQ | MP | C6070 C6095 C6111 C6997 C6999 C7567 C7787 C7802 C7864 C8141 C8143 C8146 C8182 C8220 C8552 C8568 C8571 C8573 C8581 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Nizatidine | Capsule 150 mg | Oral | a | Nizac | RF | MP NP |
|
| 60 | 5 | 60 |
|
|
a | Tacidine | AF | MP NP |
|
| 60 | 5 | 60 |
|
| |||
a | Tazac | RW | MP NP |
|
| 60 | 5 | 60 |
|
| |||
Capsule 300 mg | Oral | a | Nizac | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Tacidine | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Tazac | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Norethisterone | Tablet 5 mg | Oral |
| Primolut N | BN | MP NP |
|
| 30 | 2 | 30 |
|
|
Tablets 350 micrograms, 28 | Oral |
| Noriday 28 Day | PF | MP NP |
|
| 4 | 2 | 4 |
|
| |
Norethisterone with ethinylestradiol | Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets | Oral | a | Brevinor-1 | PF | MP NP |
|
| 4 | 2 | 4 |
|
|
a | Norimin-1 28 Day | FZ | MP NP |
|
| 4 | 2 | 4 |
|
| |||
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets | Oral | a | Brevinor | PF | MP NP |
|
| 4 | 2 | 4 |
|
| |
a | Norimin 28 Day | FZ | MP NP |
|
| 4 | 2 | 4 |
|
| |||
Norethisterone with mestranol | Pack containing 21 tablets 1 mg-50 micrograms and 7 inert tablets | Oral |
| Norinyl-1/28 | PF | MP NP |
|
| 4 | 2 | 4 |
|
|
Norfloxacin | Tablet 400 mg | Oral | a | GenRx Norfloxacin | GX | MP NP | C5744 C5806 |
| 14 | 1 | 14 |
|
|
a | Nufloxib | AF | MP NP | C5744 C5806 |
| 14 | 1 | 14 |
|
| |||
a | Roxin | RW | MP NP | C5744 C5806 |
| 14 | 1 | 14 |
|
| |||
Nortriptyline | Tablet 10 mg (as hydrochloride) | Oral | a | Allegron | RW | MP NP | C6235 C6300 |
| 50 | 2 | 50 |
|
|
a | NortriTABS 10 mg | GH | MP NP | C6235 C6300 |
| 50 | 2 | 50 |
|
| |||
Tablet 25 mg (as hydrochloride) | Oral | a | Allegron | RW | MP NP | C6235 C6300 |
| 50 | 2 | 50 |
|
| |
a | NortriTABS 25 mg | GH | MP NP | C6235 C6300 |
| 50 | 2 | 50 |
|
| |||
Nusinersen | Solution for injection 12 mg in 5 mL | Injection |
| Spinraza | BD | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Nystatin | Capsule 500,000 units | Oral |
| Nilstat | QA | MP NP PDP |
|
| 50 | 0 | 50 |
|
|
Cream 100,000 units per g, 15 g | Application |
| Mycostatin | FM | MP NP | C6434 |
| 2 | 3 | 1 |
|
| |
Tablet 500,000 units | Oral |
| Nilstat | QA | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |
Obinutuzumab | Solution for I.V. infusion 1000 mg in 40 mL | Injection |
| Gazyva | RO | MP | C7935 C7936 C7950 C7959 C7968 C7981 C8184 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Ocrelizumab | Solution concentrate for I.V. infusion 300 mg in 10 mL | Injection |
| Ocrevus | RO | MP | C7386 C7412 C7699 C7771 |
| 2 | 0 | 1 |
| D(100) |
Ocriplasmin | Solution concentrate for intravitreal injection 0.5 mg in 0.2 mL | Injection |
| Jetrea | IJ | MP | C6601 |
| 1 | 0 | 1 |
|
|
Octreotide | Injection 50 micrograms (as acetate) in 1 mL | Injection | a | Hospira Pty Limited | PF | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) |
a | Octreotide (SUN) | RA | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Octreotide MaxRx | GQ | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Sandostatin 0.05 | NV | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
Injection 100 micrograms (as acetate) in 1 mL | Injection | a | Hospira Pty Limited | PF | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |
a | Octreotide (SUN) | RA | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Octreotide MaxRx | GQ | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Sandostatin 0.1 | NV | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
Injection 500 micrograms (as acetate) in 1 mL | Injection | a | Hospira Pty Limited | PF | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |
a | Octreotide (SUN) | RA | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Octreotide MaxRx | GQ | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
a | Sandostatin 0.5 | NV | MP | C6369 C6388 C6390 C6477 C8148 C8165 |
| 90 | 11 | 5 |
| D(100) | |||
Injection (modified release) 10 mg (as acetate), vial and diluent syringe | Injection |
| Sandostatin LAR | NV | MP | C5899 C5901 C5906 C5910 C8161 C8196 C8197 C8198 C8208 |
| 2 | 5 | 1 |
| D(100) | |
Injection (modified release) 20 mg (as acetate), vial and diluent syringe | Injection |
| Sandostatin LAR | NV | MP | C5899 C5901 C5906 C5910 C8161 C8196 C8197 C8198 C8208 |
| 2 | 5 | 1 |
| D(100) | |
Injection (modified release) 30 mg (as acetate), vial and diluent syringe | Injection |
| Sandostatin LAR | NV | MP | C5899 C5901 C5906 C5910 C8161 C8196 C8197 C8198 C8208 |
| 2 | 5 | 1 |
| D(100) | |
Ofatumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | Injection |
| Arzerra | NV | MP | C4828 |
| See Note 3 | See Note 3 | 3 |
| D(100) |
Solution concentrate for I.V. infusion 1000 mg in 50 mL | Injection |
| Arzerra | NV | MP | C4828 C4858 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Ofloxacin | Eye drops 3 mg per mL, 5 mL | Application to the eye |
| Ocuflox | AG | AO | C4181 |
| 2 | 0 | 1 |
|
|
MP | C4195 |
| 2 | 0 | 1 |
|
| ||||||
Olanzapine | Powder for injection 210 mg (as pamoate monohydrate) with diluent | Injection |
| Zyprexa Relprevv | LY | MP NP | C4304 |
| 2 | 5 | 1 |
|
|
Powder for injection 300 mg (as pamoate monohydrate) with diluent | Injection |
| Zyprexa Relprevv | LY | MP NP | C4304 |
| 2 | 5 | 1 |
|
| |
Powder for injection 405 mg (as pamoate monohydrate) with diluent | Injection |
| Zyprexa Relprevv | LY | MP NP | C4304 |
| 1 | 5 | 1 |
|
| |
Tablet 2.5 mg | Oral | a | APO-Olanzapine | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
a | Olanzapine AN | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine APOTEX | GX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine RBX | RA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine Sandoz | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Ozin 2.5 | DO | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | PRYZEX | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zypine | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zyprexa | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 5 mg | Oral | a | APO-Olanzapine | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
a | Olanzapine AN | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine APOTEX | GX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine RBX | RA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine Sandoz | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Ozin 5 | DO | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | PRYZEX | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zypine | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zyprexa | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 5 mg (orally disintegrating) | Oral |
| APO-Olanzapine ODT | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Olanzapine AN ODT | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine ODT generichealth 5 | GQ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine ODT-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine Sandoz ODT 5 | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| PRYZEX ODT | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 7.5 mg | Oral |
| APO-Olanzapine | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Olanzapine AN | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine APOTEX | GX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine RBX | RA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine Sandoz | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Ozin 7.5 | DO | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| PRYZEX | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Zypine | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Zyprexa | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 7.5 mg (as benzoate) | Oral |
| Olanzapine generichealth 7.5 | GQ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
Tablet 10 mg | Oral | a | APO-Olanzapine | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
a | Olanzapine AN | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine APOTEX | GX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine RBX | RA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine Sandoz | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Olanzapine-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Ozin 10 | DO | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | PRYZEX | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zypine | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
a | Zyprexa | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 10 mg (orally disintegrating) | Oral |
| APO-Olanzapine ODT | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Olanzapine AN ODT | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine ODT generichealth 10 | GQ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine ODT-DRLA | RZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine Sandoz ODT 10 | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| PRYZEX ODT | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Tablet 15 mg (orally disintegrating) | Oral |
| APO-Olanzapine ODT | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Olanzapine AN ODT | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine Sandoz ODT 15 | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
|
|
| PRYZEX ODT | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
Tablet 20 mg (orally disintegrating) | Oral |
| APO-Olanzapine ODT | TX | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Olanzapine AN ODT | EA | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
| Olanzapine Sandoz ODT 20 | SZ | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
|
|
| PRYZEX ODT | RW | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
Wafer 5 mg | Oral |
| Zypine ODT | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Zyprexa Zydis | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Wafer 10 mg | Oral |
| Zypine ODT | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Zyprexa Zydis | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Wafer 15 mg | Oral |
| Zypine ODT | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Zyprexa Zydis | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Wafer 20 mg | Oral |
| Zypine ODT | AF | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |
| Zyprexa Zydis | LY | MP NP | C5856 C5869 |
| 28 | 5 | 28 |
|
| |||
Olaparib | Capsule 50 mg | Oral |
| Lynparza | AP | MP | C6705 C6715 C6716 |
| 448 | 5 | 448 |
|
|
| Tablet 100 mg | Oral |
| Lynparza | AP | MP | C8132 C8169 C8171 C8188 C8202 C8203 | P8132 P8202 P8203 | 112 | 2 | 56 |
|
|
|
|
|
|
|
| MP | C8132 C8169 C8171 C8188 C8202 C8203 | P8169 P8171 P8188 | 112 | 5 | 56 |
|
|
| Tablet 150 mg | Oral |
| Lynparza | AP | MP | C8132 C8169 C8171 C8188 C8202 C8203 | P8132 P8202 P8203 | 112 | 2 | 56 |
|
|
|
|
|
|
|
| MP | C8132 C8169 C8171 C8188 C8202 C8203 | P8169 P8171 P8188 | 112 | 5 | 56 |
|
|
Olmesartan | Tablet containing olmesartan medoxomil 20 mg | Oral | a | APO-Olmesartan | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
a | OLMERTAN | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan - MYL | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmetec | MK | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Olmesartan 20 | CR | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing olmesartan medoxomil 40 mg | Oral | a | APO-Olmesartan | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | OLMERTAN | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan - MYL | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmesartan Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Olmetec | MK | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Olmesartan 40 | CR | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) | Oral | a | Olmesartan/Amlodipine 20/5 APOTEX | TX | MP NP | C4373 |
| 30 | 5 | 30 |
|
|
a | Olmesartan/Amlodipine - MYL 20/5 | AF | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
a | Sevikar 20/5 | AL | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral | a | Olmesartan/Amlodipine 40/5 APOTEX | TX | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |
a | Olmesartan/Amlodipine - MYL 40/5 | AF | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
a | Sevikar 40/5 | AL | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral | a | Olmesartan/Amlodipine 40/10 APOTEX | TX | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |
a | Olmesartan/Amlodipine - MYL 40/10 | AF | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
a | Sevikar 40/10 | AL | MP NP | C4373 |
| 30 | 5 | 30 |
|
| |||
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Sevikar HCT 20/5/12.5 | MK | MP NP | C4311 |
| 30 | 5 | 30 |
|
|
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Sevikar HCT 40/5/12.5 | MK | MP NP | C4311 |
| 30 | 5 | 30 |
|
| |
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral |
| Sevikar HCT 40/5/25 | MK | MP NP | C4311 |
| 30 | 5 | 30 |
|
| |
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Sevikar HCT 40/10/12.5 | MK | MP NP | C4311 |
| 30 | 5 | 30 |
|
| |
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral |
| Sevikar HCT 40/10/25 | MK | MP NP | C4311 |
| 30 | 5 | 30 |
|
| |
Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral | a | APO-Olmesartan/HCTZ 20/12.5 | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
|
a | OLMERTAN COMBI 20/12.5 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT - MYL 20/12.5 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT AN 20/12.5 | EA | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmetec Plus | MK | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Olmesartan HCTZ 20/12.5 | CR | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral | a | APO-Olmesartan/HCTZ 40/12.5 | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |
a | OLMERTAN COMBI 40/12.5 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT - MYL 40/12.5 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT AN 40/12.5 | EA | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmetec Plus | MK | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Olmesartan HCTZ 40/12.5 | CR | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | a | APO-Olmesartan/HCTZ 40/25 | TX | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |
a | OLMERTAN COMBI 40/25 | RW | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT - MYL 40/25 | AF | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan HCT AN 40/25 | EA | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmesartan/HCT Sandoz | SZ | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Olmetec Plus | MK | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
a | Pharmacor Olmesartan HCTZ 40/25 | CR | MP NP | C4374 |
| 30 | 5 | 30 |
|
| |||
Olsalazine | Capsule containing olsalazine sodium 250 mg | Oral |
| Dipentum | IX | MP NP | C4824 |
| 100 | 5 | 100 |
|
|
Tablet containing olsalazine sodium 500 mg | Oral |
| Dipentum | IX | MP NP | C4824 |
| 100 | 5 | 100 |
|
| |
Omalizumab | Injection 75 mg in 0.5 mL single dose pre-filled syringe | Injection |
| Xolair | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Injection 150 mg in 1 mL single dose pre-filled syringe | Injection |
| Xolair | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Omeprazole | Capsule 20 mg | Oral |
| APO-Omeprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
| Maxor | AF | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Omeprazole Sandoz | HX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Pemzo | RW | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Pharmacor Omeprazole 20 | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Probitor | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| APO-Omeprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Maxor | AF | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Omeprazole Sandoz | HX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Pemzo | RW | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Pharmacor Omeprazole 20 | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Probitor | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
Tablet 10 mg (as magnesium) | Oral |
| Losec Tablets | AP | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |
Tablet 20 mg | Oral |
| APO-Omeprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |
| Meprazol | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Omeprazole AN | EA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Omeprazole generichealth | GQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Ozmep | ZP | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Pharmacor Omeprazole | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| APO-Omeprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Meprazol | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Omeprazole AN | EA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Omeprazole generichealth | GQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Ozmep | ZP | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Pharmacor Omeprazole | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
Tablet 20 mg (as magnesium) | Oral |
| Acimax Tablets | AL | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |
| Losec Tablets | AP | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Omepral | ZA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Omeprazole Sandoz | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
| |||
| Acimax Tablets | AL | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Losec Tablets | AP | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Omepral | ZA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
| Omeprazole Sandoz | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| |||
Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | a | Ondansetron Alphapharm | AF | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
|
MP | C5749 |
| 1 | 0 | 1 |
| C(100) | ||||||
a | Onsetron | ZP | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
| |||
MP | C5749 |
| 1 | 0 | 1 |
| C(100) | ||||||
I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | a | Ondansetron Alphapharm | AF | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
| |
MP | C5749 |
| 1 | 0 | 1 |
| C(100) | ||||||
a | Onsetron | ZP | MP NP | C4077 C4092 |
| 1 | 0 | 1 |
|
| |||
MP | C5749 |
| 1 | 0 | 1 |
| C(100) | ||||||
Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL | Oral |
| Zofran syrup 50 mL | AS | MP NP | C4102 C5721 | P5721 | 1 | 0 | 1 |
|
| |
MP | C5778 |
| 1 | 0 | 1 |
| C(100) | ||||||
MP NP | C4102 C5721 | P4102 | 1 | 1 | 1 |
|
| ||||||
Tablet (orally disintegrating) 4 mg | Oral |
| Ondansetron AN ODT | EA | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron Mylan ODT | AF | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron ODT GH | GQ | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron ODT-DRLA | RZ | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron SZ ODT | HX | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron AN ODT | EA | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron Mylan ODT | AF | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron ODT GH | GQ | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron ODT-DRLA | RZ | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron SZ ODT | HX | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Zilfojim ODT 4 | DO | MP NP | C5777 |
| 10 | 1 | 10 |
|
| |||
Tablet 4 mg (as hydrochloride dihydrate) | Oral | a | APO-Ondansetron | TX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron AN | EA | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron APOTEX | GX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
|
|
| MP | C5778 |
| 4 | 0 | 4 |
| C(100) | |||
a | Ondansetron Mylan Tablets | AF | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron SZ | HX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron-DRLA | RZ | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Onsetron 4 | ZP | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Zofran | AS | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | APO-Ondansetron | TX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron AN | EA | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron APOTEX | GX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron Mylan Tablets | AF | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron SZ | HX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron-DRLA | RZ | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Onsetron 4 | ZP | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Zofran | AS | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
Tablet (orally disintegrating) 8 mg | Oral |
| Ondansetron AN ODT | EA | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron Mylan ODT | AF | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron ODT GH | GQ | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron ODT-DRLA | RZ | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron SZ ODT | HX | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |||
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
| Ondansetron AN ODT | EA | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron Mylan ODT | AF | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron ODT GH | GQ | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron ODT-DRLA | RZ | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Ondansetron SZ ODT | HX | MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| |||
| Zilfojim ODT 8 | DO | MP NP | C5777 |
| 10 | 1 | 10 |
|
| |||
Tablet 8 mg (as hydrochloride dihydrate) | Oral | a | APO-Ondansetron | TX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron AN | EA | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron APOTEX | GX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
|
|
| MP | C5778 |
| 4 | 0 | 4 |
| C(100) | |||
a | Ondansetron Mylan Tablets | AF | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron SZ | HX | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Ondansetron-DRLA | RZ | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Onsetron 8 | ZP | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | Zofran | AS | MP NP | C4102 C4118 | P4118 | 4 | 0 | 4 |
|
| |||
MP | C5778 |
| 4 | 0 | 4 |
| C(100) | ||||||
a | APO-Ondansetron | TX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron AN | EA | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron APOTEX | GX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron Mylan Tablets | AF | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron SZ | HX | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Ondansetron-DRLA | RZ | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Onsetron 8 | ZP | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
a | Zofran | AS | MP NP | C4102 C4118 | P4102 | 10 | 1 | 10 |
|
| |||
Wafer 4 mg | Oral |
| Zofran Zydis | AS | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| ||||||
Wafer 8 mg | Oral |
| Zofran Zydis | AS | MP NP | C5618 C5777 | P5618 | 4 | 0 | 4 |
|
| |
MP | C5743 |
| 4 | 0 | 4 |
| C(100) | ||||||
MP NP | C5618 C5777 | P5777 | 10 | 1 | 10 |
|
| ||||||
Osimertinib | Tablet 40 mg | Oral |
| Tagrisso | AP | MP | C8537 C8538 |
| 30 | 5 | 30 |
|
|
| Tablet 80 mg | Oral |
| Tagrisso | AP | MP | C8524 C8537 C8538 |
| 30 | 5 | 30 |
|
|
Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection |
| Oxaliplatin SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection |
| DBL Oxaliplatin Concentrate | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Oxaliplatin Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Oxaliplatin SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Oxaliplatin SZ | HX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Solution concentrate for I.V. infusion 200 mg in 40 mL | Injection |
| Oxaliplatin SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Oxazepam | Tablet 15 mg | Oral | a | Alepam 15 | AF | MP NP PDP |
|
| 25 | 0 | 25 |
|
|
a | Serepax | QA | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Alepam 15 | AF | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | Serepax | QA | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | Alepam 15 | AF | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
a | Serepax | QA | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
Tablet 30 mg | Oral | a | Alepam 30 | AF | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |
a | APO-Oxazepam | TX | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Murelax | RW | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Serepax | QA | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Alepam 30 | AF | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | APO-Oxazepam | TX | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | Murelax | RW | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | Serepax | QA | MP NP |
| P6176 | 50 | 3 | 25 |
|
| |||
a | Alepam 30 | AF | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
a | APO-Oxazepam | TX | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
a | Murelax | RW | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
a | Serepax | QA | MP NP |
| P6217 P6230 P6262 | 50 | 5 | 25 |
|
| |||
Oxcarbazepine | Oral suspension 60 mg per mL, 250 mL | Oral |
| Trileptal | NV | MP NP | C5183 |
| 2 | 5 | 1 |
|
|
Tablet 150 mg | Oral |
| Trileptal | NV | MP NP | C5183 |
| 100 | 5 | 100 |
|
| |
Tablet 300 mg | Oral |
| Trileptal | NV | MP NP | C5183 |
| 100 | 5 | 100 |
|
| |
Tablet 600 mg | Oral |
| Trileptal | NV | MP NP | C5183 |
| 100 | 5 | 100 |
|
| |
Oxprenolol | Tablet containing oxprenolol hydrochloride 40 mg | Oral |
| Corbeton 40 | AF | MP NP |
|
| 100 | 5 | 100 |
|
|
Oxybutynin | Transdermal patches 36 mg, 8 | Transdermal |
| Oxytrol | TT | MP NP | C6243 |
| 1 | 5 | 1 |
|
|
Tablet containing oxybutynin hydrochloride 5 mg | Oral | a | Ditropan | SW | MP NP | C6241 |
| 100 | 5 | 100 |
|
| |
a | Oxybutynin Sandoz | SZ | MP NP | C6241 |
| 100 | 5 | 100 |
|
| |||
Oxycodone | Capsule containing oxycodone hydrochloride 5 mg | Oral | a | Oxycodone BNM | LI | PDP | C4926 |
| 20 | 0 | 20 |
|
|
|
|
| MP NP | C4959 |
| 20 | 0 | 20 |
|
| |||
a | OxyNorm | MF | PDP | C4926 |
| 20 | 0 | 20 |
|
| |||
MP NP | C4959 |
| 20 | 0 | 20 |
|
| ||||||
Capsule containing oxycodone hydrochloride 10 mg | Oral | a | Oxycodone BNM | LI | PDP | C4926 |
| 20 | 0 | 20 |
|
| |
|
|
| MP NP | C4959 |
| 20 | 0 | 20 |
|
| |||
a | OxyNorm | MF | PDP | C4926 |
| 20 | 0 | 20 |
|
| |||
MP NP | C4959 |
| 20 | 0 | 20 |
|
| ||||||
Capsule containing oxycodone hydrochloride 20 mg | Oral | a | Oxycodone BNM | LI | MP NP | C4959 |
| 20 | 0 | 20 |
|
| |
a | OxyNorm | MF | MP NP | C4959 |
| 20 | 0 | 20 |
|
| |||
Oral solution containing oxycodone hydrochloride 1 mg per mL, 250 mL | Oral |
| OxyNorm Liquid 1mg/mL | MF | PDP | C4926 |
| 1 | 0 | 1 |
|
| |
MP NP | C4959 |
| 1 | 0 | 1 |
|
| ||||||
Suppository 30 mg (as pectinate) | Rectal |
| Proladone | FF | MP NP | C4959 |
| 12 | 0 | 12 |
|
| |
PDP | C4926 |
| 12 | 0 | 12 |
|
| ||||||
Tablet containing oxycodone hydrochloride 5 mg | Oral | a | Endone | QA | MP NP | C4959 |
| 20 | 0 | 20 |
|
| |
PDP | C4926 |
| 20 | 0 | 20 |
|
| ||||||
a | Mayne Pharma Oxycodone IR | YN | MP NP | C4959 |
| 20 | 0 | 20 |
|
| |||
PDP | C4926 |
| 20 | 0 | 20 |
|
| ||||||
a | Oxycodone Aspen | FM | MP NP | C4959 |
| 20 | 0 | 20 |
|
| |||
PDP | C4926 |
| 20 | 0 | 20 |
|
| ||||||
Tablet containing oxycodone hydrochloride 10 mg (controlled release) | Oral | a | Novacodone | HX | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
a | Oxycodone Sandoz | SZ | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
a | OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
Tablet containing oxycodone hydrochloride 15 mg (controlled release) | Oral |
| OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
Tablet containing oxycodone hydrochloride 20 mg (controlled release) | Oral | a | Novacodone | HX | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
a | Oxycodone Sandoz | SZ | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
a | OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
Tablet containing oxycodone hydrochloride 30 mg (controlled release) | Oral |
| OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
Tablet containing oxycodone hydrochloride 40 mg (controlled release) | Oral | a | Novacodone | HX | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
a | Oxycodone Sandoz | SZ | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
a | OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
Tablet containing oxycodone hydrochloride 80 mg (controlled release) | Oral | a | Novacodone | HX | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |
a | Oxycodone Sandoz | SZ | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
a | OxyContin | MF | MP NP | C4583 |
| 28 | 0 | 28 |
|
| |||
Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 2.5 mg with naloxone hydrochloride 1.25 mg | Oral |
| Targin 2.5/1.25 mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
|
Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg | Oral |
| Targin 5/2.5mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg | Oral |
| Targin 10/5mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 15 mg with naloxone hydrochloride 7.5 mg | Oral |
| Targin 15/7.5mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg | Oral |
| Targin 20/10mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 30 mg with naloxone hydrochloride 15 mg | Oral |
| Targin 30/15 mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg | Oral |
| Targin 40/20mg | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 60 mg with naloxone hydrochloride 30 mg | Oral |
| Targin 60/30 | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg | Oral |
| Targin 80/40 | MF | MP NP | C4951 |
| 28 | 0 | 28 |
|
| |
Oxytocin | Injection 10 I.U. in 1 mL | Injection |
| Oxytocin Sandoz | SZ | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 5 | 5 | D(MP) |
Paclitaxel | Solution concentrate for I.V. infusion 30 mg in 5 mL | Injection |
| Paclitaxel ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
| Paclitaxel Kabi | PK | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxin | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxel Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 5 |
| D(100) | |||
Solution concentrate for I.V. infusion 100 mg in 16.7 mL | Injection |
| Anzatax | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Paclitaxel ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxin | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Solution concentrate for I.V. infusion 150 mg in 25 mL | Injection |
| Anzatax | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Paclitaxel ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxel Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxin | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Solution concentrate for I.V. infusion 300 mg in 50 mL | Injection |
| Anzatax | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Paclitaxel Accord | OC | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxel ACT | JU | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxel Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxel Kabi | PK | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Paclitaxin | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | Injection |
| Abraxane | TS | MP | C4657 C6106 C6119 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Palbociclib | Capsule 75 mg | Oral |
| Ibrance | PF | MP | C9003 C9008 C9009 |
| 21 | 5 | 21 |
|
|
| Capsule 100 mg | Oral |
| Ibrance | PF | MP | C9003 C9008 C9009 |
| 21 | 5 | 21 |
|
|
| Capsule 125 mg | Oral |
| Ibrance | PF | MP | C9003 C9008 C9009 |
| 21 | 5 | 21 |
|
|
Paliperidone | I.M. injection (modified release) 25 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Sustenna | JC | MP NP | C4246 |
| 1 | 5 | 1 |
|
|
I.M. injection (modified release) 50 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Sustenna | JC | MP NP | C4246 |
| 1 | 5 | 1 |
|
| |
I.M. injection (modified release) 75 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Sustenna | JC | MP NP | C4246 |
| 1 | 5 | 1 |
|
| |
I.M. injection (modified release) 100 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Sustenna | JC | MP NP | C4246 |
| 1 | 5 | 1 |
|
| |
I.M. injection (modified release) 150 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Sustenna | JC | MP NP | C4246 |
| 1 | 5 | 1 |
|
| |
I.M. injection (modified release) 175 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Trinza | JC | MP NP | C6832 |
| 1 | 1 | 1 |
|
| |
I.M. injection (modified release) 263 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Trinza | JC | MP NP | C6832 |
| 1 | 1 | 1 |
|
| |
I.M. injection (modified release) 350 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Trinza | JC | MP NP | C6832 |
| 1 | 1 | 1 |
|
| |
I.M. injection (modified release) 525 mg (as palmitate) in pre-filled syringe | Injection |
| Invega Trinza | JC | MP NP | C6832 |
| 1 | 1 | 1 |
|
| |
Tablet 3 mg (prolonged release) | Oral |
| Invega | JC | MP NP | C4246 |
| 28 | 5 | 28 |
|
| |
Tablet 6 mg (prolonged release) | Oral |
| Invega | JC | MP NP | C4246 |
| 28 | 5 | 28 |
|
| |
Tablet 9 mg (prolonged release) | Oral |
| Invega | JC | MP NP | C4246 |
| 28 | 5 | 28 |
|
| |
Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection |
| Aloxi | MF | MP NP | C5686 |
| 1 | 0 | 1 |
|
|
MP | C5805 |
| 1 | 0 | 1 |
| C(100) | ||||||
Pamidronic acid | Concentrated injection containing pamidronate disodium 15 mg in 5 mL | Injection |
| Pamisol | PF | MP NP | C4877 |
| 4 | 0 | 1 |
|
|
MP | C4430 C4433 |
| 4 | 2 | 1 |
| C(100) | ||||||
Concentrated injection containing pamidronate disodium 30 mg in 10 mL | Injection |
| Pamisol | PF | MP NP | C4877 |
| 2 | 0 | 1 |
|
| |
MP | C4430 C4433 |
| 2 | 2 | 1 |
| C(100) | ||||||
Concentrated injection containing pamidronate disodium 60 mg in 10 mL | Injection |
| Pamisol | PF | MP NP | C4877 |
| 1 | 0 | 1 |
|
| |
MP | C4430 C4433 |
| 1 | 2 | 1 |
| C(100) | ||||||
Concentrated injection containing pamidronate disodium 90 mg in 10 mL | Injection |
| Pamisol | PF | MP | C4430 C4433 C5218 C5256 C5257 C5291 |
| 1 | 11 | 1 |
| PB(100) | |
Pancreatic extract | Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity | Oral |
| Creon 10,000 | GO | MP NP |
|
| 500 | 10 | 100 |
|
|
MP |
| P5779 | 500 | 21 | 100 |
|
| ||||||
Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity | Oral |
| Creon 25,000 | GO | MP NP |
|
| 200 | 10 | 100 |
|
| |
MP |
| P5779 | 200 | 21 | 100 |
|
| ||||||
Capsule (containing enteric coated minimicrospheres) providing not less than 40,000 BP units of lipase activity | Oral |
| Creon 40,000 | GO | MP NP |
|
| 200 | 10 | 100 |
|
| |
MP |
| P5779 | 200 | 21 | 100 |
|
| ||||||
Granules (enteric coated) providing not less than 5,000 BP units of lipase activity per 100 mg, 20 g | Oral |
| Creon Micro | GO | MP NP |
|
| 3 | 10 | 1 |
|
| |
MP |
| P5779 | 3 | 21 | 1 |
|
| ||||||
Pancrelipase | Capsule (containing enteric coated microtablets) providing not less than 25,000 BP units of lipase activity | Oral |
| Panzytrat 25000 | TM | MP NP |
|
| 200 | 10 | 100 |
|
|
MP |
| P5779 | 200 | 21 | 100 |
|
| ||||||
Panitumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | Injection |
| Vectibix | AN | MP | C5439 C5447 C5452 C5526 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution concentrate for I.V. infusion 400 mg in 20 mL | Injection |
| Vectibix | AN | MP | C5439 C5447 C5452 C5526 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Pantoprazole | Sachet containing granules 40 mg (as sodium sesquihydrate) | Oral |
| Somac | NQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
| ||||||
Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | Oral | a | APO-Pantoprazole | TX | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |
a | APOTEX-Pantoprazole | GX | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Ozpan | RA | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Panthron | ER | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Panto | TK | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Pantofast 20 | RZ | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Pantoprazole AN | EA | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Pantoprazole APOTEX | TY | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Pantoprazole generichealth | HQ | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Pantoprazole Sandoz | SZ | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Salpraz | AF | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Somac | NQ | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
a | Sozol | RW | MP NP | C5444 C5512 C5529 |
| 30 | 5 | 30 |
|
| |||
| Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | Oral | a | APO-Pantoprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | APOTEX-Pantoprazole | GX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | I-Pantoprazole | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Ozpan | RA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Panthron | ER | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Panto | TK | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole Actavis | ED | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole AN | EA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole APOTEX | TY | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole generichealth | HQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole GH | GQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Pantoprazole Sandoz | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Salpraz | AF | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Somac | NQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | Sozol | RW | MP NP | C8774 C8775 C8776 C8780 C8866 | P8774 P8775 | 30 | 1 | 30 |
|
|
|
|
| a | APO-Pantoprazole | TX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | APOTEX-Pantoprazole | GX | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | I-Pantoprazole | CR | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Ozpan | RA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Panthron | ER | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Panto | TK | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole Actavis | ED | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole AN | EA | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole APOTEX | TY | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole generichealth | HQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole GH | GQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Pantoprazole Sandoz | SZ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Salpraz | AF | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Somac | NQ | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
|
|
| a | Sozol | RW | MP NP | C8774 C8775 C8776 C8780 C8866 | P8776 P8780 P8866 | 30 | 5 | 30 |
|
|
Paracetamol | Suppositories 500 mg, 24 | Rectal |
| Panadol | GC | MP NP | C6167 |
| 4 | 3 | 1 |
|
|
Oral liquid 120 mg per 5 mL, 100 mL | Oral |
| Panamax | SW | PDP | C5846 |
| 1 | 0 | 1 |
|
| |
MP NP | C5835 |
| 1 | 2 | 1 |
|
| ||||||
Oral liquid 240 mg per 5 mL, 200 mL | Oral |
| Panamax 240 Elixir | SW | PDP | C5846 |
| 1 | 0 | 1 |
|
| |
MP NP | C5835 |
| 1 | 2 | 1 |
|
| ||||||
Tablet 500 mg | Oral | a | APO-Paracetamol | TX | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |
a | Febridol | EA | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Mendeleev Paracetamol | HX | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Panamax | SW | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Paracetamol Generic Health | GQ | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Paracetamol (Sandoz) | SZ | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Paralgin | OW | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | Parapane | AF | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | PHARMACY CARE PARACETAMOL | SI | PDP | C5846 C5885 | P5846 | 100 | 0 | 100 |
|
| |||
a | APO-Paracetamol | TX | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Febridol | EA | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Mendeleev Paracetamol | HX | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Panamax | SW | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Paracetamol Generic Health | GQ | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Paracetamol (Sandoz) | SZ | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Paralgin | OW | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | Parapane | AF | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | PHARMACY CARE PARACETAMOL | SI | MP NP | C5835 C5865 | P5835 | 100 | 1 | 100 |
|
| |||
a | APO-Paracetamol | TX | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Febridol | EA | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Mendeleev Paracetamol | HX | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Panamax | SW | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Paracetamol Generic Health | GQ | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Paracetamol (Sandoz) | SZ | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Paralgin | OW | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | Parapane | AF | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | PHARMACY CARE PARACETAMOL | SI | PDP | C5846 C5885 | P5885 | 300 | 0 | 100 |
|
| |||
a | APO-Paracetamol | TX | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Febridol | EA | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Mendeleev Paracetamol | HX | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Panamax | SW | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Paracetamol Generic Health | GQ | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Paracetamol (Sandoz) | SZ | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Paralgin | OW | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | Parapane | AF | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
a | PHARMACY CARE PARACETAMOL | SI | MP NP | C5835 C5865 | P5865 | 300 | 4 | 100 |
|
| |||
Tablet 665 mg (modified release) | Oral | a | APOHEALTH Osteo Relief Paracetamol 665 mg | TX | MP NP | C6225 C6280 | P6225 | 192 | 3 | 96 |
|
| |
a | Osteomol 665 Paracetamol | CR | MP NP | C6225 C6280 | P6225 | 192 | 3 | 96 |
|
| |||
MP NP | C6225 C6280 | P6225 | 192 | 3 | 192 |
|
| ||||||
a | APOHEALTH Osteo Relief Paracetamol 665 mg | TX | MP NP | C6225 C6280 | P6280 | 192 | 5 | 96 |
|
| |||
a | Osteomol 665 Paracetamol | CR | MP NP | C6225 C6280 | P6280 | 192 | 5 | 96 |
|
| |||
MP NP | C6225 C6280 | P6280 | 192 | 5 | 192 |
|
| ||||||
Paraffin | Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye |
| Poly Visc | IQ | MP NP AO |
|
| 2 | 5 | 1 |
|
|
MP |
| P5713 | 2 | 11 | 1 |
|
| ||||||
Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye | a | Ircal | PE | MP NP AO |
|
| 1 | 5 | 1 |
|
| |
| Poly Visc | IQ | MP NP AO |
|
| 1 | 5 | 1 |
|
| |||
a | Refresh Night Time | AG | MP NP AO |
|
| 1 | 5 | 1 |
|
| |||
a | Ircal | PE | MP |
| P4894 | 1 | 11 | 1 |
|
| |||
| Poly Visc | IQ | MP |
| P4894 | 1 | 11 | 1 |
|
| |||
a | Refresh Night Time | AG | MP |
| P4894 | 1 | 11 | 1 |
|
| |||
Paraffin with retinol palmitate | Eye ointment, compound, containing liquid paraffin, light liquid paraffin, wool fat, white soft paraffin and retinol palmitate, 5 g | Application to the eye |
| VitA-POS | AE | AO MP NP |
|
| 2 | 5 | 1 |
|
|
MP |
| P4072 | 2 | 11 | 1 |
|
| ||||||
Paroxetine | Tablet 20 mg (as hydrochloride) | Oral | a | APO-Paroxetine | TX | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
|
a | Aropax | AS | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Chem mart Paroxetine | CH | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Extine 20 | RW | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | GenRx Paroxetine | GX | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Paroxetine AN | EA | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Paroxetine GH | GQ | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Paroxetine Sandoz | SZ | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Paxtine | AF | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Roxet 20 | DO | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
a | Terry White Chemists Paroxetine | TW | MP NP | C4755 C6277 C6636 |
| 30 | 5 | 30 |
|
| |||
Pasireotide | Injection (modified release) 20 mg (as embonate), vial and diluent syringe | Injection |
| Signifor LAR | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Injection (modified release) 40 mg (as embonate), vial and diluent syringe | Injection |
| Signifor LAR | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Injection (modified release) 60 mg (as embonate), vial and diluent syringe | Injection |
| Signifor LAR | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Pazopanib | Tablet 200 mg (as hydrochloride) | Oral |
| Votrient | NV | MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P7422 P7459 | 30 | 5 | 30 |
|
|
MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P4444 P8551 | 90 | 2 | 90 |
|
| ||||||
MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P7423 P7457 P7458 | 90 | 5 | 90 |
|
| ||||||
Tablet 400 mg (as hydrochloride) | Oral |
| Votrient | NV | MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P7422 P7459 | 30 | 5 | 30 |
|
| |
MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P4444 P8551 | 60 | 2 | 60 |
|
| ||||||
MP | C4444 C7422 C7423 C7457 C7458 C7459 C8551 | P7423 P7457 P7458 | 60 | 5 | 60 |
|
| ||||||
Pegfilgrastim | Injection 6 mg in 0.6 mL single use pre-filled syringe | Injection | a | Neulasta | JU | MP | C7822 C7823 C7843 C7862 |
| 1 | 11 | 1 |
| D(100) |
a | Ristempa | JO | MP | C7822 C7823 C7843 C7862 |
| 1 | 11 | 1 |
| D(100) | |||
|
|
| a | Tezmota | JX | MP | C7822 C7823 C7843 C7862 |
| 1 | 11 | 1 |
| D(100) |
Peginterferon alfa-2a | Injection 135 micrograms in 0.5 mL single use pre-filled syringe | Injection |
| Pegasys | RO | MP NP |
|
| 4 | 5 | 4 |
|
|
|
|
|
|
|
| MP |
| P5004 P5016 | 8 | 5 | 4 |
| C(100) |
| Injection 180 micrograms in 0.5 mL single use pre-filled syringe | Injection |
| Pegasys | RO | MP |
| P6745 | 4 | 2 | 4 |
| C(100) |
|
|
|
|
|
| MP NP |
|
| 4 | 5 | 4 |
|
|
|
|
|
|
|
| MP |
| P5004 P5016 | 8 | 5 | 4 |
| C(100) |
Peginterferon beta-1a | Single use injection pen containing 125 micrograms in 0.5 mL | Injection |
| Plegridy | BD | MP | C6860 C7695 | P7695 | 2 | 4 | 2 |
|
|
MP | C6860 C7695 | P6860 | 2 | 5 | 2 |
|
| ||||||
Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL | Injection |
| Plegridy | BD | MP | C7695 |
| 1 | 0 | 1 |
|
| |
Pegvisomant | Injection set containing powder for injection 10 mg, 30 and diluent, 30 | Injection |
| Somavert | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) |
Injection set containing powder for injection 15 mg, 30 and diluent, 30 | Injection |
| Somavert | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Injection set containing powder for injection 20 mg, 1 and diluent, 1 | Injection |
| Somavert | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Injection set containing powder for injection 20 mg, 30 and diluent, 30 | Injection |
| Somavert | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 1 |
| D(100) | |
Pembrolizumab | Powder for injection 50 mg | Injection |
| Keytruda | MK | MP | C7606 C7610 C7773 C9044 C9127 C9178 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Solution concentrate for I.V. infusion 100 mg in 4 mL | Injection |
| Keytruda | MK | MP | C7606 C7610 C7773 C8122 C8123 C8124 C8542 C8543 C8563 C9044 C9127 C9178 |
| See Note 3 | See Note 3 | 1 |
| D(100) | |
Pemetrexed | Powder for I.V. infusion 100 mg (as disodium) | Injection |
| Alimta | LY | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) |
| DBL Pemetrexed | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed Accord | OD | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| PEMETREXED-DRLA | RZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Reladdin | AF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Tevatrexed | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Powder for I.V. infusion 500 mg (as disodium) | Injection |
| Alimta | LY | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| DBL Pemetrexed | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed Accord | OD | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed APOTEX | TX | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed DRLA | RZ | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Reladdin | AF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Tevatrexed | TB | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Powder for I.V. infusion 1 g (as disodium) | Injection |
| DBL Pemetrexed | PF | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |
| Pemetrexed Accord | OD | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
| Pemetrexed SUN | RA | MP |
|
| See Note 3 | See Note 3 | 1 |
| D(100) | |||
Penicillamine | Tablet 125 mg | Oral |
| D-Penamine | AL | MP NP |
|
| 100 | 1 | 100 |
|
|
Tablet 250 mg | Oral |
| D-Penamine | AL | MP NP |
|
| 100 | 1 | 100 |
|
| |
Perampanel | Tablet 2 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP | C4656 C7815 |
| 14 | 1 | 7 |
|
|
| Tablet 4 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP NP | C4658 C7789 | P7789 | 28 | 2 | 28 |
|
|
|
|
|
|
|
| MP NP | C4658 C7789 | P4658 | 28 | 5 | 28 |
|
|
| Tablet 6 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP NP | C4658 C7789 | P7789 | 28 | 2 | 28 |
|
|
|
|
|
|
|
| MP NP | C4658 C7789 | P4658 | 28 | 5 | 28 |
|
|
| Tablet 8 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP NP | C4658 C7789 |
| 28 | 5 | 28 |
|
|
| Tablet 10 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP NP | C4658 C7789 |
| 28 | 5 | 28 |
|
|
| Tablet 12 mg (as hemisesquihydrate) | Oral |
| Fycompa | EI | MP NP | C4658 C7789 |
| 28 | 5 | 28 |
|
|
Perfluorohexyloctane | Eye drops, 3 mL | Application to the eye |
| Novatears | AE | AO MP NP | C6172 |
| 1 | 5 | 1 |
|
|
Perhexiline | Tablet containing perhexiline maleate 100 mg | Oral |
| Pexsig | QA | MP NP | C5592 |
| 100 | 5 | 100 |
|
|
Periciazine | Tablet 2.5 mg | Oral |
| Neulactil | SW | MP NP |
|
| 100 | 5 | 100 |
|
|
| Tablet 2.5 mg, 84 | Oral |
| Neulactil | SW | MP NP |
|
| 84 | 5 | 84 |
|
|
| Tablet 10 mg | Oral |
| Neulactil | SW | MP NP |
|
| 100 | 5 | 100 |
|
|
| Tablet 10 mg, 84 | Oral |
| Neulactil | SW | MP NP |
|
| 84 | 5 | 84 |
|
|
Perindopril | Tablet containing perindopril erbumine 2 mg | Oral |
| APO-Perindopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
| Blooms the Chemist Perindopril | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Chem mart Perindopril | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Idaprex 2 | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Indosyl Mono 2 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindo | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril Actavis 2 | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril AN | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Terry White Chemists Perindopril | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril arginine 2.5 mg | Oral |
| APO-Perindopril Arginine | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
| Coversyl 2.5mg | SE | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| PREXUM 2.5 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril erbumine 4 mg | Oral |
| APO-Perindopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
| Blooms the Chemist Perindopril | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Chem mart Perindopril | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Idaprex 4 | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Indosyl Mono 4 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindo | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril Actavis 4 | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril AN | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Terry White Chemists Perindopril | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril arginine 5 mg | Oral |
| APO-Perindopril Arginine | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
| Coversyl 5mg | SE | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| PREXUM 5 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril erbumine 8 mg | Oral |
| APO-Perindopril | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
| Blooms the Chemist Perindopril | IB | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Chem mart Perindopril | CH | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Idaprex 8 | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Indosyl Mono 8 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindo | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril Actavis 8 | ED | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril AN | EF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Perindopril generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| Terry White Chemists Perindopril | TW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril arginine 10 mg | Oral |
| APO-Perindopril Arginine | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
| Coversyl 10mg | SE | MP NP |
|
| 30 | 5 | 30 |
|
| |||
| PREXUM 10 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Perindopril with amlodipine | Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral | a | APO-Perindopril Arginine/Amlodipine 5/5 | TX | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
|
a | Coveram 5/5 | SE | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
a | Reaptan 5/5 | RW | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral | a | APO-Perindopril Arginine/Amlodipine 5/10 | TX | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |
a | Coveram 5/10 | SE | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
a | Reaptan 5/10 | RW | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral | a | APO-Perindopril Arginine/Amlodipine 10/5 | TX | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |
a | Coveram 10/5 | SE | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
a | Reaptan 10/5 | RW | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral | a | APO-Perindopril Arginine/Amlodipine 10/10 | TX | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |
a | Coveram 10/10 | SE | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
a | Reaptan 10/10 | RW | MP NP | C4398 C4418 |
| 30 | 5 | 30 |
|
| |||
Perindopril with indapamide | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | Oral | a | Coversyl Plus LD 2.5mg/0.625mg | SE | MP NP |
|
| 30 | 5 | 30 |
|
|
a | PREXUM Combi LD 2.5/0.625 | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral |
| GenRx Perindopril/ Indapamide 4/1.25 | GX | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |
| Idaprex Combi 4/1.25 | SZ | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
| Indosyl Combi 4/1.25 | RW | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
| Perindo Combi 4/1.25 | AF | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
| Perindopril and Indapamide AN 4/1.25 | EF | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
| Perindopril Combi Actavis 4/1.25 | ED | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
| Perindopril/ Indapamide GH 4/1.25 | GQ | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral |
| Coversyl Plus 5mg/1.25mg | SE | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |
| Prexum Combi 5/1.25 | RW | MP NP | C4375 |
| 30 | 5 | 30 |
|
| |||
Permethrin | Cream 50 mg per g, 30 g | Application |
| Lyclear | JT | MP NP |
|
| 1 | 1 | 1 |
|
|
Pertuzumab | Solution for I.V. infusion 420 mg in 14 mL | Injection |
| Perjeta | RO | MP | C4971 C5013 C5023 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Phenelzine | Tablet 15 mg (as sulfate) | Oral |
| Nardil | LM | MP | C6236 |
| 100 | 1 | 100 |
|
|
Tablet 15 mg (as sulfate) (USP) | Oral |
| Nardil | LM | MP | C6236 |
| 100 | 1 | 60 |
|
| |
Phenobarbital | Injection 200 mg (as sodium) in 1 mL | Injection |
| Fawns and McAllan Proprietary Limited | FM | MP NP | C6295 |
| 5 | 0 | 5 |
|
|
Tablet 30 mg | Oral |
| Phenobarb | RW | MP NP | C6295 |
| 200 | 4 | 200 |
|
| |
Phenoxybenzamine | Capsule containing 10 mg phenoxybenzamine hydrochloride | Oral |
| Dibenzyline | BZ | MP NP | C6145 C6178 |
| 100 | 5 | 100 |
|
|
Capsule containing phenoxybenzamine hydrochloride 10 mg | Oral |
| Dibenyline | GH | MP NP | C6145 C6178 |
| 100 | 5 | 100 |
|
| |
Capsules containing phenoxybenzamine hydrochloride 10 mg, 30 | Oral |
| Amdipharm Mercury (Australia) Pty Limited | GH | MP NP | C6145 C6178 |
| 3 | 5 | 1 |
|
| |
Phenoxymethylpenicillin | Capsule 250 mg phenoxymethylpenicillin (as potassium) | Oral |
| Cilicaine VK | FM | MP NP PDP |
|
| 50 | 0 | 50 |
|
|
| LPV | IL | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
| Cilicaine VK | FM | MP NP |
| P5697 | 50 | 5 | 50 |
|
| |||
| LPV | IL | MP NP |
| P5697 | 50 | 5 | 50 |
|
| |||
Capsule 500 mg phenoxymethylpenicillin (as potassium) | Oral |
| Cilicaine VK | FM | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |
| LPV | IL | MP NP PDP |
|
| 50 | 0 | 50 |
|
| |||
Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL | Oral |
| Cilicaine V | FM | PDP |
|
| 2 | 0 | 1 |
|
| |
MP NP |
|
| 2 | 1 | 1 |
|
| ||||||
Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL | Oral |
| Phenoxymethylpenicillin-AFT | AE | PDP |
|
| 2 | 0 | 1 |
|
| |
MP NP |
|
| 2 | 1 | 1 |
|
| ||||||
Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL | Oral |
| Phenoxymethylpenicillin-AFT | AE | PDP |
|
| 2 | 0 | 1 |
|
| |
MP NP |
|
| 2 | 1 | 1 |
|
| ||||||
Tablet 250 mg phenoxymethylpenicillin (as potassium) | Oral |
| Aspecillin VK | QA | MP NP PDP |
|
| 50 | 0 | 25 |
|
| |
MP NP |
| P5697 | 50 | 5 | 25 |
|
| ||||||
Tablet 500 mg phenoxymethylpenicillin (as potassium) | Oral |
| Aspecillin VK | QA | MP NP PDP |
|
| 50 | 0 | 25 |
|
| |
Phenylalanine with carbohydrate | Sachets of oral powder 4 g containing 50 mg phenylalanine, 30 (Phenylalanine 50) | Oral |
| Phenylalanine 50 | VF | MP NP | C5533 |
| 4 | 5 | 1 |
|
|
Phenytoin | Capsule containing phenytoin sodium 30 mg | Oral |
| Dilantin Sodium | PF | MP NP |
|
| 200 | 2 | 200 |
|
|
Capsule containing phenytoin sodium 100 mg | Oral |
| Dilantin Sodium | PF | MP NP |
|
| 200 | 2 | 200 |
|
| |
Oral suspension 30 mg per 5 mL, 500 mL | Oral |
| Dilantin | PF | MP NP |
|
| 1 | 3 | 1 |
|
| |
Tablet 50 mg | Oral |
| Dilantin Infatabs | PF | MP NP |
|
| 200 | 2 | 200 |
|
| |
Phytomenadione | Injection 10 mg in 1 mL | Injection/oral |
| Konakion MM | PB | See Note 4 | See Note 4 | See Note 4 | See Note 4 | See Note 4 | 5 | 5 | D(MP) |
Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL | Application to the eye |
| Isopto Carpine | NV | MP AO |
|
| 1 | 5 | 1 |
|
|
Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL | Application to the eye |
| Isopto Carpine | NV | MP AO |
|
| 1 | 5 | 1 |
|
| |
Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL | Application to the eye |
| Isopto Carpine | NV | MP AO |
|
| 1 | 5 | 1 |
|
| |
Pimecrolimus | Cream 10 mg per g, 15 g | Application |
| Elidel | GO | MP | C5472 C5482 |
| 1 | 1 | 1 |
|
|
Pindolol | Tablet 5 mg | Oral |
| Barbloc 5 | AF | MP NP |
|
| 100 | 5 | 100 |
|
|
Pioglitazone | Tablet 15 mg (as hydrochloride) | Oral | a | Acpio 15 | RF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
|
a | Actaze | RW | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Actos | TK | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | APOTEX-Pioglitazone | TX | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone AN | EA | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone Sandoz | SZ | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Vexazone | AF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
Tablet 30 mg (as hydrochloride) | Oral | a | Acpio 30 | RF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |
a | Actaze | RW | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Actos | TK | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | APOTEX-Pioglitazone | TX | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone AN | EA | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone Sandoz | SZ | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Vexazone | AF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
Tablet 45 mg (as hydrochloride) | Oral | a | Acpio 45 | RF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |
a | Actaze | RW | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Actos | TK | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | APOTEX-Pioglitazone | TX | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone AN | EA | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Pioglitazone Sandoz | SZ | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
a | Vexazone | AF | MP NP | C4363 C4364 C4388 |
| 28 | 5 | 28 |
|
| |||
Pirfenidone | Capsule 267 mg | Oral |
| Esbriet | RO | MP | C6950 C6961 C6975 |
| 270 | 5 | 270 |
|
|
| Tablet 267 mg | Oral |
| Esbriet | RO | MP | C6950 C6961 C6975 |
| 270 | 5 | 90 |
|
|
| Tablet 801mg | Oral |
| Esbriet | RO | MP | C6961 |
| 90 | 5 | 90 |
|
|
Piroxicam | Capsule 10 mg | Oral | a | APO-Piroxicam | TX | PDP | C6214 |
| 50 | 0 | 50 |
|
|
a | Feldene | PF | PDP | C6214 |
| 50 | 0 | 50 |
|
| |||
a | GenRx Piroxicam | GX | PDP | C6214 |
| 50 | 0 | 50 |
|
| |||
a | Mobilis 10 | AF | PDP | C6214 |
| 50 | 0 | 50 |
|
| |||
a | APO-Piroxicam | TX | MP NP | C6214 |
| 50 | 3 | 50 |
|
| |||
a | Feldene | PF | MP NP | C6214 |
| 50 | 3 | 50 |
|
| |||
a | GenRx Piroxicam | GX | MP NP | C6214 |
| 50 | 3 | 50 |
|
| |||
a | Mobilis 10 | AF | MP NP | C6214 |
| 50 | 3 | 50 |
|
| |||
Capsule 20 mg | Oral | a | APO-Piroxicam | TX | PDP | C6214 |
| 25 | 0 | 25 |
|
| |
a | Feldene | PF | PDP | C6214 |
| 25 | 0 | 25 |
|
| |||
a | GenRx Piroxicam | GX | PDP | C6214 |
| 25 | 0 | 25 |
|
| |||
a | Mobilis 20 | AF | PDP | C6214 |
| 25 | 0 | 25 |
|
| |||
a | APO-Piroxicam | TX | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
a | Feldene | PF | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
a | GenRx Piroxicam | GX | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
a | Mobilis 20 | AF | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
Dispersible tablet 10 mg | Oral |
| Mobilis D-10 | AF | PDP | C6214 |
| 50 | 0 | 50 |
|
| |
MP NP | C6214 |
| 50 | 3 | 50 |
|
| ||||||
Dispersible tablet 20 mg | Oral | a | Feldene-D | PF | PDP | C6214 |
| 25 | 0 | 25 |
|
| |
a | Mobilis D-20 | AF | PDP | C6214 |
| 25 | 0 | 25 |
|
| |||
a | Feldene-D | PF | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
a | Mobilis D-20 | AF | MP NP | C6214 |
| 25 | 3 | 25 |
|
| |||
Pizotifen | Tablet 500 micrograms (as malate) | Oral |
| Sandomigran 0.5 | AE | MP NP |
|
| 100 | 2 | 100 |
|
|
Plerixafor | Injection 24 mg in 1.2 mL | Injection |
| Mozobil | GZ | MP | C4549 C4550 |
| 1 | 1 | 1 |
| D(100) |
Pneumococcal vaccine - polyvalent | Injection 0.5 mL (23 valent) | Injection |
| Pneumovax 23 | CS | MP NP | C5595 C5596 |
| 1 | 0 | 1 |
|
|
Polyethylene glycol 400 with propylene glycol | Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28 | Application to the eye |
| Systane | AQ | AO MP NP | C6172 |
| 2 | 5 | 1 |
|
|
Eye drops 4 mg-3 mg per mL, 15 mL | Application to the eye |
| Systane | AQ | AO | C6120 |
| 1 | 5 | 1 |
|
| |
MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| ||||||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| ||||||
Poly-l-lactic acid | Powder for injection 150 mg | Injection |
| Sculptra | GA | MP | C5087 C5122 | P5122 | 2 | 0 | 1 |
|
|
MP | C5087 C5122 | P5087 | 2 | 4 | 1 |
|
| ||||||
Polyvinyl alcohol | Eye drops 14 mg per mL, 15 mL | Application to the eye | a | Liquifilm Tears | AG | MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
|
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
AO | C6120 |
| 1 | 5 | 1 |
|
| ||||||
a | PVA Tears | PE | MP | C6073 C6098 | P6073 | 1 | 5 | 1 |
|
| |||
NP | C6073 |
| 1 | 5 | 1 |
|
| ||||||
AO | C6120 |
| 1 | 5 | 1 |
|
| ||||||
a | Liquifilm Tears | AG | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
a | PVA Tears | PE | MP | C6073 C6098 | P6098 | 1 | 11 | 1 |
|
| |||
Pomalidomide | Capsule 3 mg | Oral |
| Pomalyst | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) |
Capsule 4 mg | Oral |
| Pomalyst | CJ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | 21 |
| D(100) | |
Ponatinib | Tablet 15 mg (as hydrochloride) | Oral |
| Iclusig | TS | MP | C5572 C5589 C7901 C7914 C7926 C8818 C8863 C8864 C8899 | P5572 P5589 P7901 P7914 P7926 | 60 | 2 | 60 |
|
|
MP | C5572 C5589 C7901 C7914 C7926 C8818 C8863 C8864 C8899 | P8818 P8863 P8864 P8899 | 60 | 5 | 60 |
|
| ||||||
Tablet 45 mg (as hydrochloride) | Oral |
| Iclusig | TS | MP | C5572 C5589 C7901 C7914 C7926 C8818 C8863 C8864 C8899 | P5572 P5589 P7901 P7914 P7926 | 30 | 2 | 30 |
|
| |
MP | C5572 C5589 C7901 C7914 C7926 C8818 C8863 C8864 C8899 | P8818 P8863 P8864 P8899 | 30 | 5 | 30 |
|
| ||||||
Posaconazole | Oral suspension 40 mg per mL, 105 mL | Oral |
| Noxafil | MK | MP NP | C5617 C5724 C5747 |
| 1 | 0 | 1 |
|
|
Tablet (modified release) 100 mg | Oral |
| Noxafil | MK | MP NP | C5169 C5395 C5396 |
| 24 | 0 | 24 |
|
| |
Potassium chloride | Tablet 600 mg (sustained release) | Oral |
| Span-K | AS | MP NP |
|
| 200 | 1 | 200 |
|
|
Potassium chloride with potassium bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | Oral |
| Chlorvescent | AS | MP NP |
|
| 60 | 1 | 60 |
|
|
Pralatrexate | Solution for I.V. infusion 20 mg in 1 mL | Injection |
| Folotyn | MF | MP | C7526 C7558 |
| See Note 3 | See Note 3 | 1 |
| D(100) |
Pramipexole | Tablet containing pramipexole dihydrochloride monohydrate 125 micrograms | Oral | a | APO-Pramipexole | TX | MP NP | C5363 |
| 30 | 0 | 30 |
|
|
a | Pramipexole AN | EA | MP NP | C5363 |
| 30 | 0 | 30 |
|
| |||
a | Sifrol | BY | MP NP | C5363 C5411 | P5363 | 30 | 0 | 30 |
|
| |||
a | Simipex 0.125 | RW | MP NP | C5363 |
| 30 | 0 | 30 |
|
| |||
a | Simpral | AF | MP NP | C5363 |
| 30 | 0 | 30 |
|
| |||
| Sifrol | BY | MP NP | C5363 C5411 | P5411 | 30 | 2 | 30 |
|
| |||
Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms | Oral |
| Sifrol | BY | MP NP | C5363 C5411 | P5411 | 100 | 2 | 100 |
|
| |
a | APO-Pramipexole | TX | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Pramipexole AN | EA | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Sifrol | BY | MP NP | C5363 C5411 | P5363 | 100 | 5 | 100 |
|
| |||
a | Simipex 0.25 | RW | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Simpral | AF | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 375 micrograms | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 750 micrograms | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet containing pramipexole dihydrochloride monohydrate 1 mg | Oral | a | APO-Pramipexole | TX | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |
a | Pramipexole AN | EA | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Sifrol | BY | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Simipex 1 | RW | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
a | Simpral | AF | MP NP | C5363 |
| 100 | 5 | 100 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg | Oral | a | APO-Pramipexole ER | TX | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |
a | Pramipexole XR GP | AF | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | Sifrol ER | BY | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
a | SIMIPEX XR | RW | MP NP | C5131 |
| 30 | 5 | 30 |
|
| |||
Prasugrel | Tablet 5 mg (as hydrochloride) | Oral |
| Effient | LY | MP NP | C6454 |
| 28 | 5 | 28 |
|
|
Tablet 10 mg (as hydrochloride) | Oral |
| Effient | LY | MP NP | C6454 |
| 28 | 5 | 28 |
|
| |
Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral | a | APO-Pravastatin | TX | MP NP |
|
| 30 | 5 | 30 |
|
|
a | Cholstat 10 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lipostat 10 | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravachol | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Pravastatin | TX | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Cholstat 10 | AF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Lipostat 10 | RF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravachol | RW | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin AN | EA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
Tablet containing pravastatin sodium 20 mg | Oral | a | APO-Pravastatin | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Cholstat 20 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Cholvastin | RA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lipostat 20 | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravachol | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Pravastatin | TX | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Cholstat 20 | AF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Cholvastin | RA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Lipostat 20 | RF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravachol | RW | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin AN | EA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
Tablet containing pravastatin sodium 40 mg | Oral | a | APO-Pravastatin | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Cholstat 40 | AF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Cholvastin | RA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Lipostat 40 | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravachol | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Pravastatin | TX | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Cholstat 40 | AF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Cholvastin | RA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Lipostat 40 | RF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravachol | RW | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin AN | EA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
Tablet containing pravastatin sodium 80 mg | Oral | a | APO-Pravastatin | TX | MP NP |
|
| 30 | 5 | 30 |
|
| |
a | Lipostat 80 | RF | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravachol | RW | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin AN | EA | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP NP |
|
| 30 | 5 | 30 |
|
| |||
a | APO-Pravastatin | TX | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Lipostat 80 | RF | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravachol | RW | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin AN | EA | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin generichealth | GQ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
a | Pravastatin Sandoz | SZ | MP |
| P7598 | 30 | 11 | 30 |
|
| |||
Praziquantel | Tablet 600 mg | Oral |
| Biltricide | BN | MP NP | C5659 |
| 8 | 0 | 8 |
|
|
Prazosin | Tablet 1 mg (as hydrochloride) | Oral | a | APO-Prazosin | TX | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Minipress | PF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet 2 mg (as hydrochloride) | Oral | a | APO-Prazosin | TX | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Minipress | PF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet 5 mg (as hydrochloride) | Oral | a | APO-Prazosin | TX | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Minipress | PF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Prednisolone | Tablet 1 mg | Oral | a | Panafcortelone | AS | MP NP |
|
| 100 | 4 | 100 |
|
|
a | Predsolone | LN | MP NP |
|
| 100 | 4 | 100 |
|
| |||
Tablet 5 mg | Oral |
| Panafcortelone | AS | MP NP |
|
| 60 | 4 | 60 |
|
| |
| Solone | IL | MP NP |
|
| 60 | 4 | 60 |
|
| |||
Tablet 25 mg | Oral |
| Panafcortelone | AS | MP NP |
|
| 30 | 4 | 30 |
|
| |
| Solone | IL | MP NP |
|
| 30 | 4 | 30 |
|
| |||
Suppositories 5 mg (as sodium phosphate), 10 | Rectal |
| Predsol | QA | MP NP | C4872 C4893 |
| 3 | 3 | 1 |
|
| |
Enema, retention, 20 mg (as sodium phosphate) in 100 mL | Rectal |
| Predsol | QA | MP NP |
|
| 28 | 3 | 7 |
|
| |
Oral solution 5 mg (as sodium phosphate) per mL, 30 mL | Oral | a | PredMix | LN | MP NP |
|
| 1 | 5 | 1 |
|
| |
a | Redipred | AS | MP NP |
|
| 1 | 5 | 1 |
|
| |||
Prednisolone with phenylephrine | Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL | Application to the eye |
| Prednefrin Forte | AG | AO | C6087 |
| 1 | 0 | 1 |
|
|
MP NP | C6080 C6101 |
| 1 | 2 | 1 |
|
| ||||||
Prednisone | Tablet 1 mg | Oral | a | Panafcort | AS | MP NP |
|
| 100 | 4 | 100 |
|
|
a | Predsone | LN | MP NP |
|
| 100 | 4 | 100 |
|
| |||
Tablet 5 mg | Oral |
| Panafcort | AS | MP NP |
|
| 60 | 4 | 60 |
|
| |
| Sone | IL | MP NP |
|
| 60 | 4 | 60 |
|
| |||
Tablet 25 mg | Oral |
| Panafcort | AS | MP NP |
|
| 30 | 4 | 30 |
|
| |
| Sone | IL | MP NP |
|
| 30 | 4 | 30 |
|
| |||
Pregabalin | Capsule 25 mg | Oral | a | APO-Pregabalin | TX | MP NP | C4172 |
| 56 | 5 | 56 |
|
|
a | Blooms The Chemist Pregabalin | IB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | BTC PREGABALIN | JB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | LYPRALIN | RW | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyrica | PF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyzalon | AF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Neuroccord | CR | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin AMNEAL | EA | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin APOTEX | GX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin GH | GQ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin Sandoz | SZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | PREGABALIN-DRLA | RZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin-Teva | TB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
Capsule 75 mg | Oral | a | APO-Pregabalin | TX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |
a | Blooms The Chemist Pregabalin | IB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | BTC PREGABALIN | JB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | LYPRALIN | RW | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyrica | PF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyzalon | AF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Neuroccord | CR | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin AMNEAL | EA | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin APOTEX | GX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin GH | GQ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin Sandoz | SZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | PREGABALIN-DRLA | RZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin-Teva | TB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
Capsule 150 mg | Oral | a | APO-Pregabalin | TX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |
a | Blooms The Chemist Pregabalin | IB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | BTC PREGABALIN | JB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | LYPRALIN | RW | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyrica | PF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyzalon | AF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Neuroccord | CR | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin AMNEAL | EA | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin APOTEX | GX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin GH | GQ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin Sandoz | SZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | PREGABALIN-DRLA | RZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin-Teva | TB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
Capsule 300 mg | Oral | a | APO-Pregabalin | TX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |
a | Blooms The Chemist Pregabalin | IB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | BTC PREGABALIN | JB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | LYPRALIN | RW | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyrica | PF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Lyzalon | AF | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Neuroccord | CR | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin AMNEAL | EA | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin APOTEX | GX | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin GH | GQ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin Sandoz | SZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | PREGABALIN-DRLA | RZ | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
a | Pregabalin-Teva | TB | MP NP | C4172 |
| 56 | 5 | 56 |
|
| |||
Primidone | Tablet 250 mg | Oral |
| Mysoline | LM | MP NP |
|
| 200 | 2 | 200 |
|
|
Probenecid | Tablet 500 mg | Oral |
| Pro-Cid | FF | MP NP |
|
| 100 | 5 | 100 |
|
|
Procaine benzylpenicillin | Injection 1.5 g in disposable syringe | Injection |
| Cilicaine | QA | MP NP PDP |
|
| 5 | 0 | 5 |
|
|
Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | Injection |
| Stemetil | SW | MP NP PDP |
|
| 10 | 0 | 10 |
|
|
Tablet containing prochlorperazine maleate 5 mg | Oral | a | APO-Prochlorperazine | TX | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |
a | ProCalm | RW | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Prochlorperazine AN | EA | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Prochlorperazine GH | GQ | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Stemetil | SW | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
a | Stemzine | AV | MP NP PDP |
|
| 25 | 0 | 25 |
|
| |||
Progesterone | Capsule 200 mg | Vaginal |
| Utrogestan | HB | MP | C4997 |
| 42 | 0 | 42 |
| D(100) |
Vaginal gel (prolonged release) 90 mg in single dose pre-filled applicator | Vaginal |
| Crinone 8% | SG | MP | C5045 |
| 30 | 0 | 15 |
| D(100) | |
Pessary 100 mg | Vaginal |
| Oripro | ON | MP | C4997 |
| 45 | 0 | 15 |
| D(100) | |
Pessary 200 mg | Vaginal |
| Oripro | ON | MP | C4997 |
| 45 | 0 | 15 |
| D(100) | |
Vaginal tablet 100 mg | Vaginal |
| Endometrin | FP | MP | C4997 |
| 42 | 0 | 21 |
| D(100) | |
Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | Injection |
| Hospira Pty Limited | PF | MP NP PDP |
|
| 10 | 0 | 5 |
|
|
Propantheline | Tablet containing propantheline bromide 15 mg | Oral |
| Pro-Banthine | RW | MP NP | C6241 |
| 200 | 5 | 100 |
|
|
Propranolol | Tablet containing propranolol hydrochloride 10 mg | Oral | a | APO-Propranolol | TX | MP NP |
|
| 100 | 5 | 100 |
|
|
a | Deralin 10 | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Inderal | AP | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet containing propranolol hydrochloride 40 mg | Oral | a | APO-Propranolol | TX | MP NP |
|
| 100 | 5 | 100 |
|
| |
a | Deralin 40 | AF | MP NP |
|
| 100 | 5 | 100 |
|
| |||
a | Inderal | AP | MP NP |
|
| 100 | 5 | 100 |
|
| |||
Tablet containing propranolol hydrochloride 160 mg | Oral |
| Deralin 160 | AF | MP NP |
|
| 50 | 5 | 50 |
|
| |
Propylthiouracil | Tablet 50 mg | Oral |
| PTU | FF | MP NP |
|
| 200 | 2 | 100 |
|
|
Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docosahexaenoic acid | Oral liquid 130 mL, 30 (PKU Easy) | Oral |
| PKU Easy | OH | MP NP | C5970 |
| 5 | 5 | 1 |
|
|
Protein formula with carbohydrate, fat, vitamins and minerals | Oral liquid 500 mL, 8 (Nutrini Peptisorb Energy) | Oral |
| Nutrini Peptisorb Energy | NU | MP NP | C6890 |
| 10 | 5 | 1 |
|
|
Protein hydrolysate formula with medium chain triglycerides | Oral powder 400 g (Alfaré) | Oral |
| Alfaré | NT | MP NP | C6137 C6138 C6148 C6157 C6158 C6166 C6174 C6182 C6193 C6194 C6195 C6204 C6205 C6206 |
| 8 | 5 | 1 |
|
|
Oral powder 450 g (Aptamil Gold+ Pepti-Junior) | Oral |
| Aptamil Gold+ Pepti-Junior | NU | MP NP | C6137 C6138 C6148 C6157 C6158 C6166 C6174 C6182 C6193 C6194 C6195 C6204 C6205 |
| 8 | 5 | 1 |
|
| |
Pyrantel | Tablet 125 mg (as embonate) | Oral |
| Anthel 125 | AF | MP NP |
|
| 6 | 0 | 6 |
|
|
Tablet 250 mg (as embonate) | Oral |
| Anthel 250 | AF | MP NP |
|
| 6 | 0 | 6 |
|
| |
Pyridostigmine | Tablet containing pyridostigmine bromide 10 mg | Oral |
| Mestinon | IL | MP |
|
| 100 | 5 | 50 |
|
|
Tablet containing pyridostigmine bromide 60 mg | Oral |
| Mestinon | IL | MP |
|
| 150 | 5 | 150 |
|
| |
Tablet containing pyridostigmine bromide 180 mg (modified release) | Oral |
| Mestinon Timespan | IL | MP |
|
| 100 | 5 | 50 |
|
|